<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">migraine </span>
   <span class="font29">patients </span>
   <span class="font25">headache </span>
   <span class="font19">Headache </span>
   <span class="font17">study </span>
   <span class="font17">treatment </span>
   <span class="font16">(.) </span>
   <span class="font16">University </span>
   <span class="font15">chronic </span>
   <span class="font15">Department </span>
   <span class="font14">days </span>
   <span class="font14">pain </span>
   <span class="font14">clinical </span>
   <span class="font14">Correspondence: </span>
   <span class="font13">Migraine </span>
   <span class="font13">baseline </span>
   <span class="font13">compared </span>
   <span class="font13">mean </span>
   <span class="font13">associated </span>
   <span class="font13">episodic </span>
   <span class="font12">number </span>
   <span class="font12">frequency </span>
   <span class="font12">medication </span>
   <span class="font12">data </span>
   <span class="font12">placebo </span>
   <span class="font12">preventive </span>
   <span class="font12">response </span>
   <span class="font12">Neurology, </span>
   <span class="font12">acute </span>
   <span class="font12">monthly </span>
   <span class="font12">studies </span>
   <span class="font12">Italy; </span>
   <span class="font12">efficacy </span>
   <span class="font12">migraine. </span>
   <span class="font12">analysis </span>
   <span class="font12">aura </span>
   <span class="font12">primary </span>
   <span class="font12">attacks </span>
   <span class="font12">patient </span>
   <span class="font12">Neurology </span>
   <span class="font12">higher </span>
   <span class="font12">Medical </span>
   <span class="font12">age </span>
   <span class="font12">months </span>
   <span class="font12">significant </span>
   <span class="font12">using </span>
   <span class="font12">headaches </span>
   <span class="font12">patients. </span>
   <span class="font12">reported </span>
   <span class="font12">use </span>
   <span class="font12">Patients </span>
   <span class="font12">USA; </span>
   <span class="font12">years </span>
   <span class="font12">reduction </span>
   <span class="font11">group </span>
   <span class="font11">received </span>
   <span class="font11">significantly </span>
   <span class="font11">(%) </span>
   <span class="font11">Results: </span>
   <span class="font11">disability </span>
   <span class="font11">used </span>
   <span class="font11">Clinical </span>
   <span class="font11">included </span>
   <span class="font11">Hospital, </span>
   <span class="font11">.±. </span>
   <span class="font11">Health </span>
   <span class="font11">symptoms </span>
   <span class="font11">Results </span>
   <span class="font11">galcanezumab </span>
   <span class="font11">Center, </span>
   <span class="font11">[]. </span>
   <span class="font11">results </span>
   <span class="font11">Medicine, </span>
   <span class="font11">Methods: </span>
   <span class="font11">change </span>
   <span class="font11">erenumab </span>
   <span class="font11">vs. </span>
   <span class="font11">Research </span>
   <span class="font11">approved </span>
   <span class="font11">(.%) </span>
   <span class="font11">high </span>
   <span class="font11">according </span>
   <span class="font11">brain </span>
   <span class="font11">month </span>
   <span class="font11">showed </span>
   <span class="font11">subjects </span>
   <span class="font11">migraine, </span>
   <span class="font11">(abstract </span>
   <span class="font11">effect </span>
   <span class="font11">headache. </span>
   <span class="font11">average </span>
   <span class="font11">different </span>
   <span class="font11">overuse </span>
   <span class="font11">Italy </span>
   <span class="font11">criteria </span>
   <span class="font11">diagnosis </span>
   <span class="font11">new </span>
   <span class="font11">risk </span>
   <span class="font11">therapy </span>
   <span class="font11">period </span>
   <span class="font11">Ethics </span>
   <span class="font11">Hospital </span>
   <span class="font11">based </span>
   <span class="font11">population </span>
   <span class="font11">total </span>
   <span class="font11">International </span>
   <span class="font11">Sciences, </span>
   <span class="font11">Pain </span>
   <span class="font11">daily </span>
   <span class="font11">study. </span>
   <span class="font11">(., </span>
   <span class="font11">attack </span>
   <span class="font11">observed </span>
   <span class="font11">present </span>
   <span class="font11">prior </span>
   <span class="font11">reduced </span>
   <span class="font11">role </span>
   <span class="font11">Chronic </span>
   <span class="font11">changes </span>
   <span class="font11">disease </span>
   <span class="font11">fremanezumab </span>
   <span class="font11">Background: </span>
   <span class="font11">Rome, </span>
   <span class="font11">USA </span>
   <span class="font11">CGRP </span>
   <span class="font11">P). </span>
   <span class="font11">duration </span>
   <span class="font11">greater </span>
   <span class="font11">patients, </span>
   <span class="font11">time </span>
   <span class="font11">Teva </span>
   <span class="font11">disorders </span>
   <span class="font11">effective </span>
   <span class="font11">headache, </span>
   <span class="font11">Background </span>
   <span class="font11">factors </span>
   <span class="font11">increase </span>
   <span class="font11">Unit, </span>
   <span class="font11">University, </span>
   <span class="font11">common </span>
   <span class="font11">history </span>
   <span class="font11">increased </span>
   <span class="font11">&amp;lt;. </span>
   <span class="font11">Methods </span>
   <span class="font11">groups </span>
   <span class="font11">related </span>
   <span class="font11">secondary </span>
   <span class="font11">treated </span>
   <span class="font11">Center </span>
   <span class="font11">hours </span>
   <span class="font11">including </span>
   <span class="font11">onset </span>
   <span class="font11">performed </span>
   <span class="font11">score </span>
   <span class="font11">European </span>
   <span class="font11">References </span>
   <span class="font11">approval </span>
   <span class="font11">severity </span>
   <span class="font11">treatment. </span>
   <span class="font11">Centre, </span>
   <span class="font11">conducted </span>
   <span class="font11">versus </span>
   <span class="font11">Classification </span>
   <span class="font11">prevalence </span>
   <span class="font11">differences </span>
   <span class="font11">management </span>
   <span class="font11">randomized </span>
   <span class="font10">did </span>
   <span class="font10">drug </span>
   <span class="font10">trigeminal </span>
   <span class="font10">days, </span>
   <span class="font10">dose </span>
   <span class="font10">effects </span>
   <span class="font10">pediatric </span>
   <span class="font10">(n=) </span>
   <span class="font10">Novartis </span>
   <span class="font10">association </span>
   <span class="font10">children </span>
   <span class="font10">obtained </span>
   <span class="font10">stimulation </span>
   <span class="font10">Conclusion: </span>
   <span class="font10">Institute </span>
   <span class="font10">Lilly </span>
   <span class="font10">School </span>
   <span class="font10">levels </span>
   <span class="font10">lower </span>
   <span class="font10">phase </span>
   <span class="font10">Table </span>
   <span class="font10">characteristics </span>
   <span class="font10">impact </span>
   <span class="font10">nerve </span>
   <span class="font10">safety </span>
   <span class="font10">Department, </span>
   <span class="font10">cluster </span>
   <span class="font10">enrolled </span>
   <span class="font10">-week </span>
   <span class="font10">Conclusions: </span>
   <span class="font10">Copenhagen, </span>
   <span class="font10">evaluate </span>
   <span class="font10">rate </span>
   <span class="font10">Eli </span>
   <span class="font10">MOH </span>
   <span class="font10">aim </span>
   <span class="font10">assess </span>
   <span class="font10">burden </span>
   <span class="font10">cortical </span>
   <span class="font10">evidence </span>
   <span class="font10">improvement </span>
   <span class="font10">(-., </span>
   <span class="font10">intensity </span>
   <span class="font10">migraineurs </span>
   <span class="font10">possible </span>
   <span class="font10">presence </span>
   <span class="font10">research </span>
   <span class="font10">specific </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">Mean </span>
   <span class="font10">following </span>
   <span class="font10">health </span>
   <span class="font10">migraine: </span>
   <span class="font10">neurological </span>
   <span class="font10">severe </span>
   <span class="font10">similar </span>
   <span class="font10">type </span>
   <span class="font10">MRI </span>
   <span class="font10">assessed </span>
   <span class="font10">diagnosed </span>
   <span class="font10">diagnostic </span>
   <span class="font10">disorder </span>
   <span class="font10">findings </span>
   <span class="font10">.%, </span>
   <span class="font10">Conclusions </span>
   <span class="font10">depression </span>
   <span class="font10">double-blind, </span>
   <span class="font10">quality </span>
   <span class="font10">pressure </span>
   <span class="font10">previous </span>
   <span class="font10">sleep </span>
   <span class="font10">activity </span>
   <span class="font10">care </span>
   <span class="font10">follow-up </span>
   <span class="font10">important </span>
   <span class="font10">mechanisms </span>
   <span class="font10">participants </span>
   <span class="font10">presented </span>
   <span class="font10">central </span>
   <span class="font10">demonstrated </span>
   <span class="font10">life </span>
   <span class="font10">prophylactic </span>
   <span class="font10">therapeutic </span>
   <span class="font10">underwent </span>
   <span class="font10">Data </span>
   <span class="font10">ICHD- </span>
   <span class="font10">Week </span>
   <span class="font10">consent </span>
   <span class="font10">overall </span>
   <span class="font10">receptor </span>
   <span class="font10">scores </span>
   <span class="font10">years, </span>
   <span class="font10">Month </span>
   <span class="font10">NCT </span>
   <span class="font10">Study </span>
   <span class="font10">evaluated </span>
   <span class="font10">events </span>
   <span class="font10">medical </span>
   <span class="font10">review </span>
   <span class="font10">stroke </span>
   <span class="font10">survey </span>
   <span class="font10">work </span>
   <span class="font10">.%; </span>
   <span class="font10">Fig. </span>
   <span class="font10">calcitonin </span>
   <span class="font10">day </span>
   <span class="font10">drugs </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">Committee </span>
   <span class="font10">However, </span>
   <span class="font10">Neurological </span>
   <span class="font10">UK; </span>
   <span class="font10">antibody </span>
   <span class="font10">blood </span>
   <span class="font10">controls </span>
   <span class="font10">failed </span>
   <span class="font10">general </span>
   <span class="font10">model </span>
   <span class="font10">outcome </span>
   <span class="font10">peptide </span>
   <span class="font10">potential </span>
   <span class="font10">-.) </span>
   <span class="font10">MIDAS </span>
   <span class="font10">cerebral </span>
   <span class="font10">healthy </span>
   <span class="font10">individuals </span>
   <span class="font10">nVNS </span>
   <span class="font10">outcomes </span>
   <span class="font10">proportion </span>
   <span class="font10">treatment, </span>
   <span class="font10">women </span>
   <span class="font10">(.% </span>
   <span class="font10">New </span>
   <span class="font10">Spain; </span>
   <span class="font10">and/or </span>
   <span class="font10">attributed </span>
   <span class="font10">case </span>
   <span class="font10">cervical </span>
   <span class="font10">considered </span>
   <span class="font10">current </span>
   <span class="font10">electroCore, </span>
   <span class="font10">gene-related </span>
   <span class="font10">prevention </span>
   <span class="font10">symptom </span>
   <span class="font10">Allergan </span>
   <span class="font10">Clinic, </span>
   <span class="font10">Maria </span>
   <span class="font10">control </span>
   <span class="font10">defined </span>
   <span class="font10">identified </span>
   <span class="font10">measures </span>
   <span class="font10">test </span>
   <span class="font10">Conclusion </span>
   <span class="font10">Faculty </span>
   <span class="font10">Glostrup, </span>
   <span class="font10">TTH </span>
   <span class="font10">completed </span>
   <span class="font10">features </span>
   <span class="font10">previously </span>
   <span class="font10">rates </span>
   <span class="font10">trial </span>
   <span class="font10">Danish </span>
   <span class="font10">Erenumab </span>
   <span class="font10">London, </span>
   <span class="font10">Pavia, </span>
   <span class="font10">better </span>
   <span class="font10">difference </span>
   <span class="font10">early </span>
   <span class="font10">frequent </span>
   <span class="font10">low </span>
   <span class="font10">p=.). </span>
   <span class="font10">psychiatric </span>
   <span class="font10">quarterly </span>
   <span class="font10">relationship </span>
   <span class="font10">shown </span>
   <span class="font10">suggest </span>
   <span class="font10">visual </span>
   <span class="font10">(CM) </span>
   <span class="font10">(N=) </span>
   <span class="font10">Ashina </span>
   <span class="font10">IRCCS </span>
   <span class="font10">Medicine </span>
   <span class="font10">adverse </span>
   <span class="font10">anxiety </span>
   <span class="font10">developed </span>
   <span class="font10">double-blind </span>
   <span class="font10">monoclonal </span>
   <span class="font10">order </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">population. </span>
   <span class="font10">seen </span>
   <span class="font10">NDPH </span>
   <span class="font10">OnabotulinumtoxinA </span>
   <span class="font10">Science </span>
   <span class="font10">cause </span>
   <span class="font10">having </span>
   <span class="font10">impairment </span>
   <span class="font10">methods </span>
   <span class="font10">period. </span>
   <span class="font10">randomized, </span>
   <span class="font10">reductions </span>
   <span class="font10">relevant </span>
   <span class="font10">study, </span>
   <span class="font10">treatments </span>
   <span class="font10">week </span>
   <span class="font10">(%), </span>
   <span class="font10">(OR </span>
   <span class="font10">(Table </span>
   <span class="font10">Centre </span>
   <span class="font10">College </span>
   <span class="font10">National </span>
   <span class="font10">PBO </span>
   <span class="font10">Phase </span>
   <span class="font10">activation </span>
   <span class="font10">active </span>
   <span class="font10">analyses </span>
   <span class="font10">female </span>
   <span class="font10">followed </span>
   <span class="font10">incidence </span>
   <span class="font10">injection </span>
   <span class="font10">onabotulinumtoxinA </span>
   <span class="font10">physical </span>
   <span class="font10">vascular </span>
   <span class="font10">CA, </span>
   <span class="font10">Group </span>
   <span class="font10">Pharmaceuticals, </span>
   <span class="font10">adults </span>
   <span class="font10">aged </span>
   <span class="font10">aimed </span>
   <span class="font10">baseline, </span>
   <span class="font10">cases </span>
   <span class="font10">head </span>
   <span class="font10">intake </span>
   <span class="font10">level </span>
   <span class="font10">likely </span>
   <span class="font10">moderate </span>
   <span class="font10">normal </span>
   <span class="font10">percentage </span>
   <span class="font10">statistically </span>
   <span class="font10">weeks </span>
   <span class="font10">year </span>
   <span class="font10">(SD) </span>
   <span class="font10">(p&amp;lt;.). </span>
   <span class="font10">.). </span>
   <span class="font10">Cephalalgia </span>
   <span class="font10">Rigshospitalet </span>
   <span class="font10">affected </span>
   <span class="font10">characterized </span>
   <span class="font10">correlation </span>
   <span class="font10">does </span>
   <span class="font10">effectiveness </span>
   <span class="font10">imaging </span>
   <span class="font10">investigate </span>
   <span class="font10">local </span>
   <span class="font10">prospective </span>
   <span class="font10">(p=.). </span>
   <span class="font10">Brain </span>
   <span class="font10">Denmark </span>
   <span class="font10">Pharmaceuticals. </span>
   <span class="font10">Weeks </span>
   <span class="font10">body </span>
   <span class="font10">collected </span>
   <span class="font10">fees </span>
   <span class="font10">functional </span>
   <span class="font10">information </span>
   <span class="font10">main </span>
   <span class="font10">medications </span>
   <span class="font10">neck </span>
   <span class="font10">provided </span>
   <span class="font10">range </span>
   <span class="font10">right </span>
   <span class="font10">sample </span>
   <span class="font10">standard </span>
   <span class="font10">Germany; </span>
   <span class="font10">Health, </span>
   <span class="font10">Pharma </span>
   <span class="font10">Primary </span>
   <span class="font10">Turkey; </span>
   <span class="font10">allodynia </span>
   <span class="font10">aura. </span>
   <span class="font10">available </span>
   <span class="font10">fully </span>
   <span class="font10">involved </span>
   <span class="font10">long-term </span>
   <span class="font10">national </span>
   <span class="font10">negative </span>
   <span class="font10">open-label </span>
   <span class="font10">peripheral </span>
   <span class="font10">provide </span>
   <span class="font10">referred </span>
   <span class="font10">Basel, </span>
   <span class="font10">EVOLVE- </span>
   <span class="font10">decreased </span>
   <span class="font10">intracranial </span>
   <span class="font10">large </span>
   <span class="font10">odds </span>
   <span class="font10">respectively. </span>
   <span class="font10">site </span>
   <span class="font10">support </span>
   <span class="font10">(.%), </span>
   <span class="font10">CM. </span>
   <span class="font10">Disorders </span>
   <span class="font10">HIT- </span>
   <span class="font10">Italian </span>
   <span class="font10">Objective: </span>
   <span class="font10">Society </span>
   <span class="font10">United </span>
   <span class="font10">decrease </span>
   <span class="font10">detoxification </span>
   <span class="font10">development </span>
   <span class="font10">investigated </span>
   <span class="font10">multiple </span>
   <span class="font10">placebo, </span>
   <span class="font10">receive </span>
   <span class="font10">refractory </span>
   <span class="font10">responders </span>
   <span class="font10">sensory </span>
   <span class="font10">tertiary </span>
   <span class="font10">therapies </span>
   <span class="font10">trials </span>
   <span class="font10">triptans </span>
   <span class="font10">(Fig. </span>
   <span class="font10">Jan </span>
   <span class="font10">consecutive </span>
   <span class="font10">direct </span>
   <span class="font10">healthcare </span>
   <span class="font10">lack </span>
   <span class="font10">photophobia </span>
   <span class="font10">report </span>
   <span class="font10">suffering </span>
   <span class="font10">(/) </span>
   <span class="font10">-month </span>
   <span class="font10">AG, </span>
   <span class="font10">Denmark; </span>
   <span class="font10">Efficacy </span>
   <span class="font10">MMD </span>
   <span class="font10">Neuroscience, </span>
   <span class="font10">Questionnaire </span>
   <span class="font10">Sapienza </span>
   <span class="font10">Sciences </span>
   <span class="font10">Unit </span>
   <span class="font10">cognitive </span>
   <span class="font10">consumption </span>
   <span class="font10">controls. </span>
   <span class="font10">determine </span>
   <span class="font10">doses </span>
   <span class="font10">improved </span>
   <span class="font10">independent </span>
   <span class="font10">measured </span>
   <span class="font10">mild </span>
   <span class="font10">nausea </span>
   <span class="font10">need </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">protocol </span>
   <span class="font10">recent </span>
   <span class="font10">respondents </span>
   <span class="font10">years. </span>
   <span class="font10">(.%). </span>
   <span class="font10">;:-. </span>
   <span class="font10">AEs </span>
   <span class="font10">BMI </span>
   <span class="font10">Dr. </span>
   <span class="font10">Emergency </span>
   <span class="font10">Foundation, </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Pain. </span>
   <span class="font10">Pennsylvania, </span>
   <span class="font10">abnormal </span>
   <span class="font10">analyzed </span>
   <span class="font10">class </span>
   <span class="font10">clinically </span>
   <span class="font10">economic </span>
   <span class="font10">headaches. </span>
   <span class="font10">migrainous </span>
   <span class="font10">pain. </span>
   <span class="font10">persistent </span>
   <span class="font10">respectively, </span>
   <span class="font10">single </span>
   <span class="font10">studies. </span>
   <span class="font10">subcutaneous </span>
   <span class="font10">symptomatic </span>
   <span class="font10">tolerability </span>
   <span class="font10">trigger </span>
   <span class="font10">(mean </span>
   <span class="font10">Cephalalgia. </span>
   <span class="font10">MHDs </span>
   <span class="font10">NHS </span>
   <span class="font10">RESULTS: </span>
   <span class="font10">Treatment </span>
   <span class="font10">additional </span>
   <span class="font10">administered </span>
   <span class="font10">combined </span>
   <span class="font10">comorbidity </span>
   <span class="font10">estimated </span>
   <span class="font10">ethics </span>
   <span class="font10">experienced </span>
   <span class="font10">identify </span>
   <span class="font10">induced </span>
   <span class="font10">initial </span>
   <span class="font10">institutional </span>
   <span class="font10">literature </span>
   <span class="font10">matter </span>
   <span class="font10">months, </span>
   <span class="font10">oral </span>
   <span class="font10">p-value </span>
   <span class="font10">people </span>
   <span class="font10">pharmacological </span>
   <span class="font10">positive </span>
   <span class="font10">reducing </span>
   <span class="font10">regression </span>
   <span class="font10">values </span>
   <span class="font10">visits </span>
   <span class="font10">years) </span>
   <span class="font10">–.±. </span>
   <span class="font10">(SE) </span>
   <span class="font10">(−., </span>
   <span class="font10">Barcelona, </span>
   <span class="font10">Board </span>
   <span class="font10">Company, </span>
   <span class="font10">Foundation </span>
   <span class="font10">Introduction </span>
   <span class="font10">Lipton </span>
   <span class="font10">Materials </span>
   <span class="font10">Messoud </span>
   <span class="font10">Neuroscience </span>
   <span class="font10">Research, </span>
   <span class="font10">Spain </span>
   <span class="font10">combination </span>
   <span class="font10">comorbid </span>
   <span class="font10">controlled </span>
   <span class="font10">cortex </span>
   <span class="font10">dosing </span>
   <span class="font10">evaluation </span>
   <span class="font10">factor </span>
   <span class="font10">hospital </span>
   <span class="font10">human </span>
   <span class="font10">long </span>
   <span class="font10">monthly: </span>
   <span class="font10">months. </span>
   <span class="font10">occurrence </span>
   <span class="font10">p&amp;lt;.). </span>
   <span class="font10">parameters </span>
   <span class="font10">poor </span>
   <span class="font10">practice </span>
   <span class="font10">productivity </span>
   <span class="font10">recorded </span>
   <span class="font10">second </span>
   <span class="font10">studies, </span>
   <span class="font10">tension-type </span>
   <span class="font10">version </span>
   <span class="font10">CSD </span>
   <span class="font10">David </span>
   <span class="font10">PRESTO </span>
   <span class="font10">San </span>
   <span class="font10">Silberstein </span>
   <span class="font10">TrPs </span>
   <span class="font10">aura, </span>
   <span class="font10">concomitant </span>
   <span class="font10">condition </span>
   <span class="font10">employee </span>
   <span class="font10">examination </span>
   <span class="font10">individual </span>
   <span class="font10">magnetic </span>
   <span class="font10">meningeal </span>
   <span class="font10">min </span>
   <span class="font10">p=.) </span>
   <span class="font10">pituitary </span>
   <span class="font10">profile </span>
   <span class="font10">psychological </span>
   <span class="font10">questionnaire </span>
   <span class="font10">recruited </span>
   <span class="font10">revealed </span>
   <span class="font10">serum </span>
   <span class="font10">types </span>
   <span class="font10">vestibular </span>
   <span class="font10">vitamin </span>
   <span class="font10">weekly </span>
   <span class="font10">(p&amp;lt;.) </span>
   <span class="font10">.), </span>
   <span class="font10">Disability </span>
   <span class="font10">Federation </span>
   <span class="font10">France; </span>
   <span class="font10">LLC; </span>
   <span class="font10">METHODS: </span>
   <span class="font10">Mayo </span>
   <span class="font10">Medication </span>
   <span class="font10">Paolo </span>
   <span class="font10">Professor, </span>
   <span class="font10">RCVS </span>
   <span class="font10">Regional </span>
   <span class="font10">Review </span>
   <span class="font10">[-] </span>
   <span class="font10">administration </span>
   <span class="font10">age, </span>
   <span class="font10">attacks, </span>
   <span class="font10">benefit </span>
   <span class="font10">center </span>
   <span class="font10">conditions </span>
   <span class="font10">costs </span>
   <span class="font10">cranial </span>
   <span class="font10">described </span>
   <span class="font10">disorders. </span>
   <span class="font10">especially </span>
   <span class="font10">excitability </span>
   <span class="font10">groups. </span>
   <span class="font10">headache: </span>
   <span class="font10">increasing </span>
   <span class="font10">ischemic </span>
   <span class="font10">known </span>
   <span class="font10">mg, </span>
   <span class="font10">minutes </span>
   <span class="font10">objective </span>
   <span class="font10">outpatient </span>
   <span class="font10">particularly </span>
   <span class="font10">pathophysiology </span>
   <span class="font10">placebo. </span>
   <span class="font10">receives </span>
   <span class="font10">showing </span>
   <span class="font10">suffer </span>
   <span class="font10">systematic </span>
   <span class="font10">term </span>
   <span class="font10">-mg </span>
   <span class="font10">BoNT-A </span>
   <span class="font10">Change </span>
   <span class="font10">Child </span>
   <span class="font10">Disorders, </span>
   <span class="font10">Dodick </span>
   <span class="font10">Inc., </span>
   <span class="font10">Inc.; </span>
   <span class="font10">Indianapolis, </span>
   <span class="font10">King’s </span>
   <span class="font10">LLC, </span>
   <span class="font10">Laura </span>
   <span class="font10">Martelletti </span>
   <span class="font10">PFO </span>
   <span class="font10">Stephen </span>
   <span class="font10">Trust, </span>
   <span class="font10">[,]. </span>
   <span class="font10">achieving </span>
   <span class="font10">causes </span>
   <span class="font10">cohort </span>
   <span class="font10">cost </span>
   <span class="font10">determined </span>
   <span class="font10">frequently </span>
   <span class="font10">grants </span>
   <span class="font10">habituation </span>
   <span class="font10">infusion </span>
   <span class="font10">left </span>
   <span class="font10">male </span>
   <span class="font10">matched </span>
   <span class="font10">mechanism </span>
   <span class="font10">occur </span>
   <span class="font10">pain, </span>
   <span class="font10">protein </span>
   <span class="font10">receiving </span>
   <span class="font10">relation </span>
   <span class="font10">retinal </span>
   <span class="font10">spinal </span>
   <span class="font10">studied </span>
   <span class="font10">subgroup </span>
   <span class="font10">syndrome </span>
   <span class="font10">tension </span>
   <span class="font10">times </span>
   <span class="font10">triptan </span>
   <span class="font10">unilateral </span>
   <span class="font10">visit </span>
   <span class="font10">{border-style </span>
   <span class="font10">&amp;gt;% </span>
   <span class="font10">(EM) </span>
   <span class="font10">(quarterly: </span>
   <span class="font10">,±, </span>
   <span class="font10">American </span>
   <span class="font10">Amgen </span>
   <span class="font10">Belgium; </span>
   <span class="font10">Cristina </span>
   <span class="font10">DNA </span>
   <span class="font10">EVOLVE-, </span>
   <span class="font10">Francesca </span>
   <span class="font10">Introduction: </span>
   <span class="font10">Jefferson </span>
   <span class="font10">Neurol </span>
   <span class="font10">P&amp;lt;.) </span>
   <span class="font10">Pediatric </span>
   <span class="font10">Peter </span>
   <span class="font10">abnormalities </span>
   <span class="font10">absence </span>
   <span class="font10">admitted </span>
   <span class="font10">adolescents </span>
   <span class="font10">adult </span>
   <span class="font10">analgesics </span>
   <span class="font10">analysis. </span>
   <span class="font10">bilateral </span>
   <span class="font10">compare </span>
   <span class="font10">family </span>
   <span class="font10">gene </span>
   <span class="font10">genetic </span>
   <span class="font10">group. </span>
   <span class="font10">humanized </span>
   <span class="font10">hypertension </span>
   <span class="font10">indicate </span>
   <span class="font10">indirect </span>
   <span class="font10">longer </span>
   <span class="font10">loss </span>
   <span class="font10">mainly </span>
   <span class="font10">measure </span>
   <span class="font10">models </span>
   <span class="font10">neurons </span>
   <span class="font10">occipital </span>
   <span class="font10">occurred </span>
   <span class="font10">points </span>
   <span class="font10">randomised </span>
   <span class="font10">recurrent </span>
   <span class="font10">selected </span>
   <span class="font10">social </span>
   <span class="font10">statistical </span>
   <span class="font10">treat </span>
   <span class="font10">useful </span>
   <span class="font10">withdrawal </span>
   <span class="font10">(): </span>
   <span class="font10">Berlin, </span>
   <span class="font10">CSF </span>
   <span class="font10">Company; </span>
   <span class="font10">Florence, </span>
   <span class="font10">Global </span>
   <span class="font10">Group, </span>
   <span class="font10">Institute, </span>
   <span class="font10">Joshua </span>
   <span class="font10">Mondino </span>
   <span class="font10">PREEMPT </span>
   <span class="font10">Tassorelli </span>
   <span class="font10">Turin, </span>
   <span class="font10">achieved </span>
   <span class="font10">animal </span>
   <span class="font10">appropriate </span>
   <span class="font10">area </span>
   <span class="font10">arteries </span>
   <span class="font10">attacks. </span>
   <span class="font10">disorders, </span>
   <span class="font10">edition </span>
   <span class="font10">form </span>
   <span class="font10">frequency, </span>
   <span class="font10">highly </span>
   <span class="font10">images </span>
   <span class="font10">improve </span>
   <span class="font10">key </span>
   <span class="font10">medication. </span>
   <span class="font10">migraine-specific </span>
   <span class="font10">motor </span>
   <span class="font10">multicenter, </span>
   <span class="font10">non-invasive </span>
   <span class="font10">online </span>
   <span class="font10">options </span>
   <span class="font10">pathophysiological </span>
   <span class="font10">period, </span>
   <span class="font10">preliminary </span>
   <span class="font10">prevalent </span>
   <span class="font10">program </span>
   <span class="font10">px;} </span>
   <span class="font10">repeated </span>
   <span class="font10">respectively). </span>
   <span class="font10">resulted </span>
   <span class="font10">sTMS </span>
   <span class="font10">sensitivity </span>
   <span class="font10">sensitization </span>
   <span class="font10">small </span>
   <span class="font10">started </span>
   <span class="font10">status </span>
   <span class="font10">subgroups </span>
   <span class="font10">suggesting </span>
   <span class="font10">terms </span>
   <span class="font10">underlying </span>
   <span class="font10">various </span>
   <span class="font10">working </span>
   <span class="font10">worse </span>
   <span class="font10">−.) </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">(%). </span>
   <span class="font10">(p=.) </span>
   <span class="font10">.-. </span>
   <span class="font10">Acute </span>
   <span class="font10">Assessment </span>
   <span class="font10">CM, </span>
   <span class="font10">CONCLUSIONS: </span>
   <span class="font10">Carlo </span>
   <span class="font10">Fremanezumab </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Goadsby </span>
   <span class="font10">Informed </span>
   <span class="font10">Madrid, </span>
   <span class="font10">Scale </span>
   <span class="font10">THC-CBD </span>
   <span class="font10">Trial </span>
   <span class="font10">Vall </span>
   <span class="font10">Vincenzo </span>
   <span class="font10">[.]; </span>
   <span class="font10">able </span>
   <span class="font10">advisory </span>
   <span class="font10">analgesic </span>
   <span class="font10">applied </span>
   <span class="font10">assessment </span>
   <span class="font10">attack. </span>
   <span class="font10">brainstem </span>
   <span class="font10">cells </span>
   <span class="font10">criteria. </span>
   <span class="font10">cross-sectional </span>
   <span class="font10">dedicated </span>
   <span class="font10">differ </span>
   <span class="font10">disability. </span>
   <span class="font10">episodes </span>
   <span class="font10">expression </span>
   <span class="font10">external </span>
   <span class="font10">function </span>
   <span class="font10">good </span>
   <span class="font10">guidelines </span>
   <span class="font10">headaches, </span>
   <span class="font10">help </span>
   <span class="font10">influence </span>
   <span class="font10">informed </span>
   <span class="font10">lasmiditan </span>
   <span class="font10">major </span>
   <span class="font10">nasal </span>
   <span class="font10">older </span>
   <span class="font10">p&amp;lt;.) </span>
   <span class="font10">painful </span>
   <span class="font10">play </span>
   <span class="font10">prescribed </span>
   <span class="font10">provides </span>
   <span class="font10">puncture </span>
   <span class="font10">responses </span>
   <span class="font10">screening </span>
   <span class="font10">selectively </span>
   <span class="font10">supported </span>
   <span class="font10">therapy. </span>
   <span class="font10">trigeminovascular </span>
   <span class="font10">value </span>
   <span class="font10">white </span>
   <span class="font10">(MOH) </span>
   <span class="font10">-day </span>
   <span class="font10">Aurora </span>
   <span class="font10">Baseline </span>
   <span class="font10">Birmingham, </span>
   <span class="font10">CDH </span>
   <span class="font10">Coppola </span>
   <span class="font10">Division </span>
   <span class="font10">Elena </span>
   <span class="font10">Frazer, </span>
   <span class="font10">Gianluca </span>
   <span class="font10">Headache. </span>
   <span class="font10">Norwegian </span>
   <span class="font10">OnabotA </span>
   <span class="font10">Phoenix, </span>
   <span class="font10">Results. </span>
   <span class="font10">Secondary </span>
   <span class="font10">Sheena </span>
   <span class="font10">Switzerland </span>
   <span class="font10">addition, </span>
   <span class="font10">affect </span>
   <span class="font10">approach </span>
   <span class="font10">attention </span>
   <span class="font10">cardiovascular </span>
   <span class="font10">cerebrospinal </span>
   <span class="font10">comparison </span>
   <span class="font10">complete </span>
   <span class="font10">confirmed </span>
   <span class="font10">consistent </span>
   <span class="font10">countries </span>
   <span class="font10">course </span>
   <span class="font10">days/month </span>
   <span class="font10">della </span>
   <span class="font10">experience </span>
   <span class="font10">exposure </span>
   <span class="font10">failure </span>
   <span class="font10">females </span>
   <span class="font10">health-care </span>
   <span class="font10">hoc </span>
   <span class="font10">interventions </span>
   <span class="font10">isolated </span>
   <span class="font10">lead </span>
   <span class="font10">leading </span>
   <span class="font10">lumbar </span>
   <span class="font10">mixed </span>
   <span class="font10">mutation </span>
   <span class="font10">nICP </span>
   <span class="font10">personal </span>
   <span class="font10">phonophobia </span>
   <span class="font10">proposed </span>
   <span class="font10">published </span>
   <span class="font10">ratio </span>
   <span class="font10">remaining </span>
   <span class="font10">remains </span>
   <span class="font10">represent </span>
   <span class="font10">scale </span>
   <span class="font10">series </span>
   <span class="font10">shows </span>
   <span class="font10">suggested </span>
   <span class="font10">sustained </span>
   <span class="font10">tests </span>
   <span class="font10">treatments. </span>
   <span class="font10">upper </span>
   <span class="font10">variables </span>
   <span class="font10">volume </span>
   <span class="font10">years; </span>
   <span class="font10">(.-.) </span>
   <span class="font10">(CGRP), </span>
   <span class="font10">.%. </span>
   <span class="font10">Allergan, </span>
   <span class="font10">Anne </span>
   <span class="font10">Cerebral </span>
   <span class="font10">Curr </span>
   <span class="font10">Diener </span>
   <span class="font10">Drug </span>
   <span class="font10">Eric </span>
   <span class="font10">Ethical </span>
   <span class="font10">Experimental </span>
   <span class="font10">HDs </span>
   <span class="font10">Michael </span>
   <span class="font10">O). </span>
   <span class="font10">P=.) </span>
   <span class="font10">P=.; </span>
   <span class="font10">PACAP </span>
   <span class="font10">Safety </span>
   <span class="font10">TIA </span>
   <span class="font10">Thomas </span>
   <span class="font10">Universitario </span>
   <span class="font10">Vitamin </span>
   <span class="font10">access </span>
   <span class="font10">assigned </span>
   <span class="font10">continued </span>
   <span class="font10">days. </span>
   <span class="font10">disability, </span>
   <span class="font10">disease. </span>
   <span class="font10">disorder. </span>
   <span class="font10">end </span>
   <span class="font10">fluid </span>
   <span class="font10">focus </span>
   <span class="font10">follow </span>
   <span class="font10">forms </span>
   <span class="font10">honoraria </span>
   <span class="font10">included. </span>
   <span class="font10">inflammatory </span>
   <span class="font10">like </span>
   <span class="font10">limited </span>
   <span class="font10">medication-overuse </span>
   <span class="font10">mg) </span>
   <span class="font10">neuralgia </span>
   <span class="font10">old </span>
   <span class="font10">onset, </span>
   <span class="font10">osmophobia </span>
   <span class="font10">participation </span>
   <span class="font10">pattern </span>
   <span class="font10">platform </span>
   <span class="font10">post </span>
   <span class="font10">real </span>
   <span class="font10">red </span>
   <span class="font10">sponsored </span>
   <span class="font10">spontaneous </span>
   <span class="font10">stock </span>
   <span class="font10">taken </span>
   <span class="font10">targets </span>
   <span class="font10">treating </span>
   <span class="font10">usually </span>
   <span class="font10">vagus </span>
   <span class="font10">written </span>
   <span class="font10">young </span>
   <span class="font10">(μm) </span>
   <span class="font10">-.; </span>
   <span class="font10">-.;-. </span>
   <span class="font10">.%b </span>
   <span class="font10">:-. </span>
   <span class="font10">;():-. </span>
   <span class="font10">Albert </span>
   <span class="font10">Approval </span>
   <span class="font10">Centro </span>
   <span class="font10">Cohen </span>
   <span class="font10">Einstein </span>
   <span class="font10">Francesco </span>
   <span class="font10">Giorgio </span>
   <span class="font10">ICHD </span>
   <span class="font10">IIH </span>
   <span class="font10">Impact </span>
   <span class="font10">Inc. </span>
   <span class="font10">Ltd. </span>
   <span class="font10">MA, </span>
   <span class="font10">MSQ </span>
   <span class="font10">Neurol. </span>
   <span class="font10">Neurosurgery, </span>
   <span class="font10">OBJECTIVE: </span>
   <span class="font10">Objectives </span>
   <span class="font10">Onabotulinumtoxin </span>
   <span class="font10">Overall, </span>
   <span class="font10">Paul </span>
   <span class="font10">References: </span>
   <span class="font10">Regarding </span>
   <span class="font10">Robert </span>
   <span class="font10">Sacco </span>
   <span class="font10">Switzerland; </span>
   <span class="font10">Universidad </span>
   <span class="font10">Zhang </span>
   <span class="font10">age. </span>
   <span class="font10">altered </span>
   <span class="font10">artery </span>
   <span class="font10">causing </span>
   <span class="font10">classification </span>
   <span class="font10">confidence </span>
   <span class="font10">consultancy </span>
   <span class="font10">correlate </span>
   <span class="font10">criterion </span>
   <span class="font10">data, </span>
   <span class="font10">days). </span>
   <span class="font10">disabling </span>
   <span class="font10">diseases </span>
   <span class="font10">dysfunction </span>
   <span class="font10">emotional </span>
   <span class="font10">fulfilled </span>
   <span class="font10">global </span>
   <span class="font10">highest </span>
   <span class="font10">hypersensitivity </span>
   <span class="font10">increases </span>
   <span class="font10">index </span>
   <span class="font10">indicated </span>
   <span class="font10">induce </span>
   <span class="font10">injury </span>
   <span class="font10">leads </span>
   <span class="font10">learning </span>
   <span class="font10">multivariate </span>
   <span class="font10">networks </span>
   <span class="font10">neuronal </span>
   <span class="font10">observational </span>
   <span class="font10">onabotA </span>
   <span class="font10">open </span>
   <span class="font10">p=.), </span>
   <span class="font10">past </span>
   <span class="font10">population, </span>
   <span class="font10">possibly </span>
   <span class="font10">post-hoc </span>
   <span class="font10">predictors </span>
   <span class="font10">reduces </span>
   <span class="font10">region </span>
   <span class="font10">represents </span>
   <span class="font10">resource </span>
   <span class="font10">set </span>
   <span class="font10">spreading </span>
   <span class="font10">subgroups. </span>
   <span class="font10">sufferers </span>
   <span class="font10">superior </span>
   <span class="font10">symptoms. </span>
   <span class="font10">system. </span>
   <span class="font10">temporal </span>
   <span class="font10">tryptophan </span>
   <span class="font10">venous </span>
   <span class="font10">vomiting </span>
   <span class="font10">women, </span>
   <span class="font10">(CGRP) </span>
   <span class="font10">(CM). </span>
   <span class="font10">(n=), </span>
   <span class="font10">-item </span>
   <span class="font10">-year </span>
   <span class="font10">Associated </span>
   <span class="font10">Association </span>
   <span class="font10">Aura </span>
   <span class="font10">BACKGROUND: </span>
   <span class="font10">Based </span>
   <span class="font10">Behavioral </span>
   <span class="font10">Brighina </span>
   <span class="font10">CM: </span>
   <span class="font10">Clinic </span>
   <span class="font10">Consent </span>
   <span class="font10">Depression </span>
   <span class="font10">Effect </span>
   <span class="font10">Employee </span>
   <span class="font10">FHM </span>
   <span class="font10">Federico </span>
   <span class="font10">Galcanezumab </span>
   <span class="font10">General </span>
   <span class="font10">Grazzi </span>
   <span class="font10">Headache, </span>
   <span class="font10">Here, </span>
   <span class="font10">Institutional </span>
   <span class="font10">MMDs </span>
   <span class="font10">Marco </span>
   <span class="font10">Migraine-Specific </span>
   <span class="font10">Molecular </span>
   <span class="font10">Number </span>
   <span class="font10">OLE </span>
   <span class="font10">Ospedale </span>
   <span class="font10">Overuse </span>
   <span class="font10">Patient </span>
   <span class="font10">Pharmaceutical </span>
   <span class="font10">Philadelphia, </span>
   <span class="font10">REGAIN </span>
   <span class="font10">Training </span>
   <span class="font10">Trondheim, </span>
   <span class="font10">World </span>
   <span class="font10">York, </span>
   <span class="font10">action </span>
   <span class="font10">activities </span>
   <span class="font10">analysis, </span>
   <span class="font10">approximately </span>
   <span class="font10">areas </span>
   <span class="font10">arterial </span>
   <span class="font10">autonomic </span>
   <span class="font10">board </span>
   <span class="font10">boards, </span>
   <span class="font10">caused </span>
   <span class="font10">committees </span>
   <span class="font10">comorbidities </span>
   <span class="font10">correlated </span>
   <span class="font10">degree </span>
   <span class="font10">demographic </span>
   <span class="font10">divided </span>
   <span class="font10">epilepsy </span>
   <span class="font10">evoked </span>
   <span class="font10">fewer </span>
   <span class="font10">final </span>
   <span class="font10">given </span>
   <span class="font10">groups, </span>
   <span class="font10">hormonal </span>
   <span class="font10">include </span>
   <span class="font10">interaction </span>
   <span class="font10">investigator </span>
   <span class="font10">knowledge </span>
   <span class="font10">latent </span>
   <span class="font10">lost </span>
   <span class="font10">maintained </span>
   <span class="font10">majority </span>
   <span class="font10">network </span>
   <span class="font10">occurring </span>
   <span class="font10">occurs </span>
   <span class="font10">overuse. </span>
   <span class="font10">p&amp;lt;.), </span>
   <span class="font10">pension </span>
   <span class="font10">performance </span>
   <span class="font10">physician </span>
   <span class="font10">physicians </span>
   <span class="font10">placebo-controlled, </span>
   <span class="font10">progression </span>
   <span class="font10">pulse </span>
   <span class="font10">receptors </span>
   <span class="font10">registered </span>
   <span class="font10">required </span>
   <span class="font10">resonance </span>
   <span class="font10">responder </span>
   <span class="font10">retrospective </span>
   <span class="font10">sham </span>
   <span class="font10">stratified </span>
   <span class="font10">structured </span>
   <span class="font10">substantial </span>
   <span class="font10">suggests </span>
   <span class="font10">sumatriptan </span>
   <span class="font10">target </span>
   <span class="font10">time. </span>
   <span class="font10">tool </span>
   <span class="font10">tract </span>
   <span class="font10">transient </span>
   <span class="font10">traumatic </span>
   <span class="font10">trochlear </span>
   <span class="font10">use, </span>
   <span class="font10">variable </span>
   <span class="font10">vomiting, </span>
   <span class="font10">weight </span>
   <span class="font10">worsening </span>
   <span class="font10">yawning </span>
   <span class="font10">(). </span>
   <span class="font10">(IgGa) </span>
   <span class="font10">(NCT) </span>
   <span class="font10">(beta </span>
   <span class="font10">(–.±. </span>
   <span class="font10">.%) </span>
   <span class="font10">APPROVAL </span>
   <span class="font10">ASL </span>
   <span class="font10">Academy </span>
   <span class="font10">According </span>
   <span class="font10">Age </span>
   <span class="font10">Allergan; </span>
   <span class="font10">Analyses </span>
   <span class="font10">Antonio </span>
   <span class="font10">Barbara </span>
   <span class="font10">Burden </span>
   <span class="font10">CGRP, </span>
   <span class="font10">CI: </span>
   <span class="font10">Changes </span>
   <span class="font10">Clínico </span>
   <span class="font10">Daniel </span>
   <span class="font10">Declaration </span>
   <span class="font10">Department. </span>
   <span class="font10">Diagnostic </span>
   <span class="font10">ETHICS </span>
   <span class="font10">HFEM </span>
   <span class="font10">Headaches </span>
   <span class="font10">IN, </span>
   <span class="font10">IRCCS, </span>
   <span class="font10">Intracranial </span>
   <span class="font10">Istanbul </span>
   <span class="font10">Istituto </span>
   <span class="font10">LSM </span>
   <span class="font10">London </span>
   <span class="font10">Lorenzo </span>
   <span class="font10">L’Aquila, </span>
   <span class="font10">MSMD </span>
   <span class="font10">Milan, </span>
   <span class="font10">NY, </span>
   <span class="font10">Neurophysiology </span>
   <span class="font10">Neurosciences, </span>
   <span class="font10">Nice, </span>
   <span class="font10">Norway </span>
   <span class="font10">Norway; </span>
   <span class="font10">Oaks, </span>
   <span class="font10">P&amp;lt;.). </span>
   <span class="font10">Palermo, </span>
   <span class="font10">Palermo; </span>
   <span class="font10">Paola </span>
   <span class="font10">Public </span>
   <span class="font10">REGISTRATION: </span>
   <span class="font10">Raieli </span>
   <span class="font10">Ronghua </span>
   <span class="font10">S.p.A.; </span>
   <span class="font10">School, </span>
   <span class="font10">Service </span>
   <span class="font10">Sleep </span>
   <span class="font10">States </span>
   <span class="font10">TRIAL </span>
   <span class="font10">Test </span>
   <span class="font10">Thousand </span>
   <span class="font10">Using </span>
   <span class="font10">account </span>
   <span class="font10">age: </span>
   <span class="font10">and, </span>
   <span class="font10">asked </span>
   <span class="font10">auras </span>
   <span class="font10">characterize </span>
   <span class="font10">chronification </span>
   <span class="font10">classified </span>
   <span class="font10">clinic </span>
   <span class="font10">committee </span>
   <span class="font10">complex </span>
   <span class="font10">cost-effectiveness </span>
   <span class="font10">data. </span>
   <span class="font10">days; </span>
   <span class="font10">develop </span>
   <span class="font10">developing </span>
   <span class="font10">discontinuation </span>
   <span class="font10">drugs. </span>
   <span class="font10">dural </span>
   <span class="font10">eligible </span>
   <span class="font10">emergency </span>
   <span class="font10">endogenous </span>
   <span class="font10">environmental </span>
   <span class="font10">evaluating </span>
   <span class="font10">features. </span>
   <span class="font10">follow-up. </span>
   <span class="font10">frontal </span>
   <span class="font10">funded </span>
   <span class="font10">groups: </span>
   <span class="font10">heart </span>
   <span class="font10">illicit </span>
   <span class="font10">induction </span>
   <span class="font10">inflammation </span>
   <span class="font10">inhibition </span>
   <span class="font10">inhibitory </span>
   <span class="font10">injections </span>
   <span class="font10">intensity, </span>
   <span class="font10">international </span>
   <span class="font10">intervention </span>
   <span class="font10">lasting </span>
   <span class="font10">later </span>
   <span class="font10">layer </span>
   <span class="font10">mass </span>
   <span class="font10">means </span>
   <span class="font10">men </span>
   <span class="font10">metacognitive </span>
   <span class="font10">methylation </span>
   <span class="font10">middle </span>
   <span class="font10">mitochondrial </span>
   <span class="font10">monitoring </span>
   <span class="font10">month, </span>
   <span class="font10">mood </span>
   <span class="font10">needed </span>
   <span class="font10">needs </span>
   <span class="font10">neural </span>
   <span class="font10">neurologists </span>
   <span class="font10">neuropathic </span>
   <span class="font10">pain/tension </span>
   <span class="font10">pathways </span>
   <span class="font10">patient-reported </span>
   <span class="font10">patient. </span>
   <span class="font10">phenotype </span>
   <span class="font10">plc, </span>
   <span class="font10">position </span>
   <span class="font10">practice, </span>
   <span class="font10">processing </span>
   <span class="font10">project </span>
   <span class="font10">prospective, </span>
   <span class="font10">publish </span>
   <span class="font10">randomly </span>
   <span class="font10">rare </span>
   <span class="font10">regulations. </span>
   <span class="font10">restricted </span>
   <span class="font10">resulting </span>
   <span class="font10">service </span>
   <span class="font10">session </span>
   <span class="font10">site. </span>
   <span class="font10">subjects. </span>
   <span class="font10">symptoms, </span>
   <span class="font10">threshold </span>
   <span class="font10">widely </span>
   <span class="font10">worldwide </span>
   <span class="font10"> Week </span>
   <span class="font10">&amp;lt;% </span>
   <span class="font10">&amp;lt;.) </span>
   <span class="font10">(EM: </span>
   <span class="font10">(p=.), </span>
   <span class="font10">(range </span>
   <span class="font10">,,, </span>
   <span class="font10">,±,; </span>
   <span class="font10">ADA </span>
   <span class="font10">Anna </span>
   <span class="font10">Autonomic </span>
   <span class="font10">Bambino </span>
   <span class="font10">Birmingham </span>
   <span class="font10">Bronx, </span>
   <span class="font10">CLUB </span>
   <span class="font10">Children </span>
   <span class="font10">ClinicalTrials.gov, </span>
   <span class="font10">Cluster </span>
   <span class="font10">Current </span>
   <span class="font10">Day </span>
   <span class="font10">Discussion </span>
   <span class="font10">Discussion: </span>
   <span class="font10">EEG </span>
   <span class="font10">Facility, </span>
   <span class="font10">Fremanezumab, </span>
   <span class="font10">G., </span>
   <span class="font10">Internal </span>
   <span class="font10">Italy. </span>
   <span class="font10">JBOARD </span>
   <span class="font10">Jensen </span>
   <span class="font10">Laboratory </span>
   <span class="font10">Marina </span>
   <span class="font10">Michel </span>
   <span class="font10">Mikol </span>
   <span class="font10">NIHR-Wellcome </span>
   <span class="font10">Netherlands; </span>
   <span class="font10">Novartis; </span>
   <span class="font10">Palermo </span>
   <span class="font10">Paula </span>
   <span class="font10">Pharmaceuticals </span>
   <span class="font10">Quality </span>
   <span class="font10">Queen </span>
   <span class="font10">Raffaele </span>
   <span class="font10">STPP </span>
   <span class="font10">Science, </span>
   <span class="font10">Simona </span>
   <span class="font10">Stewart </span>
   <span class="font10">TREX </span>
   <span class="font10">TTH. </span>
   <span class="font10">Tehran, </span>
   <span class="font10">Tension </span>
   <span class="font10">Trust </span>
   <span class="font10">Università </span>
   <span class="font10">[.] </span>
   <span class="font10">ability </span>
   <span class="font10">adherence </span>
   <span class="font10">appears </span>
   <span class="font10">aspects </span>
   <span class="font10">associations </span>
   <span class="font10">blinded </span>
   <span class="font10">calculated </span>
   <span class="font10">called </span>
   <span class="font10">centre </span>
   <span class="font10">childhood </span>
   <span class="font10">commonly </span>
   <span class="font10">confirm </span>
   <span class="font10">continuous </span>
   <span class="font10">cutaneous </span>
   <span class="font10">deficiency </span>
   <span class="font10">design </span>
   <span class="font10">designed </span>
   <span class="font10">diary </span>
   <span class="font10">difficult </span>
   <span class="font10">excessive </span>
   <span class="font10">experimental </span>
   <span class="font10">extension </span>
   <span class="font10">factors. </span>
   <span class="font10">free </span>
   <span class="font10">group, </span>
   <span class="font10">high-frequency </span>
   <span class="font10">ibuprofen </span>
   <span class="font10">interactions </span>
   <span class="font10">interictal </span>
   <span class="font10">internal </span>
   <span class="font10">logistic </span>
   <span class="font10">median </span>
   <span class="font10">medicine </span>
   <span class="font10">members </span>
   <span class="font10">month. </span>
   <span class="font10">non-responders </span>
   <span class="font10">particular </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">patients’ </span>
   <span class="font10">peak </span>
   <span class="font10">phases </span>
   <span class="font10">pilot </span>
   <span class="font10">point </span>
   <span class="font10">pooled </span>
   <span class="font10">presenting </span>
   <span class="font10">provider </span>
   <span class="font10">publication: </span>
   <span class="font10">randomised, </span>
   <span class="font10">recognized </span>
   <span class="font10">registration: </span>
   <span class="font10">remained </span>
   <span class="font10">reported. </span>
   <span class="font10">respectively </span>
   <span class="font10">response. </span>
   <span class="font10">result </span>
   <span class="font10">retrospectively </span>
   <span class="font10">routine </span>
   <span class="font10">safe </span>
   <span class="font10">scan </span>
   <span class="font10">seizure </span>
   <span class="font10">sickness </span>
   <span class="font10">specificity </span>
   <span class="font10">stimuli </span>
   <span class="font10">suffered </span>
   <span class="font10">testing </span>
   <span class="font10">topiramate </span>
   <span class="font10">trauma </span>
   <span class="font10">understand </span>
   <span class="font10">unmet </span>
   <span class="font10">users </span>
   <span class="font10">women. </span>
   <span class="font10">younger </span>
   <span class="font10">İstanbul, </span>
   <span class="font10">(.±. </span>
   <span class="font10">(EVOLVE-) </span>
   <span class="font10">(IHS). </span>
   <span class="font10">AG; </span>
   <span class="font10">AZ, </span>
   <span class="font10">Acknowledgements </span>
   <span class="font10">Analysis </span>
   <span class="font10">Arizona, </span>
   <span class="font10">Average </span>
   <span class="font10">Bologna, </span>
   <span class="font10">Campus </span>
   <span class="font10">Care </span>
   <span class="font10">ClinicalTrials.gov </span>
   <span class="font10">Conclusions. </span>
   <span class="font10">DAs </span>
   <span class="font10">Disclosures: </span>
   <span class="font10">Disease </span>
   <span class="font10">Episodic </span>
   <span class="font10">Europe </span>
   <span class="font10">Food </span>
   <span class="font10">Funding </span>
   <span class="font10">Germany, </span>
   <span class="font10">Giorgia </span>
   <span class="font10">Grazia </span>
   <span class="font10">Guidelines </span>
   <span class="font10">Hanover, </span>
   <span class="font10">Hospitals </span>
   <span class="font10">Irvine, </span>
   <span class="font10">Liebler </span>
   <span class="font10">Lifting </span>
   <span class="font10">Long-term </span>
   <span class="font10">MHD </span>
   <span class="font10">MMA </span>
   <span class="font10">MMD, </span>
   <span class="font10">MOH. </span>
   <span class="font10">Mental </span>
   <span class="font10">Methods. </span>
   <span class="font10">Modena </span>
   <span class="font10">NCT, </span>
   <span class="font10">Objective </span>
   <span class="font10">PPG </span>
   <span class="font10">Pamela </span>
   <span class="font10">Piero </span>
   <span class="font10">Reggio </span>
   <span class="font10">Response </span>
   <span class="font10">Reuter </span>
   <span class="font10">Richard </span>
   <span class="font10">S.p.A. </span>
   <span class="font10">Samuela </span>
   <span class="font10">Technology, </span>
   <span class="font10">Three-month </span>
   <span class="font10">Uwe </span>
   <span class="font10">Yang </span>
   <span class="font10">[], </span>
   <span class="font10">activity. </span>
   <span class="font10">added </span>
   <span class="font10">allow </span>
   <span class="font10">analysed </span>
   <span class="font10">application </span>
   <span class="font10">beta </span>
   <span class="font10">biomarker </span>
   <span class="font10">carried </span>
   <span class="font10">consensus </span>
   <span class="font10">conventional </span>
   <span class="font10">cycle </span>
   <span class="font10">del </span>
   <span class="font10">demonstrate </span>
   <span class="font10">dependence </span>
   <span class="font10">depressive </span>
   <span class="font10">dietary </span>
   <span class="font10">digital </span>
   <span class="font10">disease, </span>
   <span class="font10">distinct </span>
   <span class="font10">dura </span>
   <span class="font10">electronic </span>
   <span class="font10">epidemiological </span>
   <span class="font10">equally </span>
   <span class="font10">evolution </span>
   <span class="font10">exercise </span>
   <span class="font10">explain </span>
   <span class="font10">explore </span>
   <span class="font10">explored </span>
   <span class="font10">female, </span>
   <span class="font10">focal </span>
   <span class="font10">gender </span>
   <span class="font10">half </span>
   <span class="font10">however, </span>
   <span class="font10">investigation </span>
   <span class="font10">items </span>
   <span class="font10">kind </span>
   <span class="font10">linear </span>
   <span class="font10">macular </span>
   <span class="font10">males </span>
   <span class="font10">manage </span>
   <span class="font10">manual </span>
   <span class="font10">marker </span>
   <span class="font10">meaningful </span>
   <span class="font10">medication, </span>
   <span class="font10">menstrual </span>
   <span class="font10">mg: </span>
   <span class="font10">model, </span>
   <span class="font10">model. </span>
   <span class="font10">month) </span>
   <span class="font10">motion </span>
   <span class="font10">n=; </span>
   <span class="font10">neurophysiological </span>
   <span class="font10">origin </span>
   <span class="font10">overuse, </span>
   <span class="font10">overweight </span>
   <span class="font10">p&amp;lt;. </span>
   <span class="font10">pain: </span>
   <span class="font10">paracetamol </span>
   <span class="font10">participated </span>
   <span class="font10">patients) </span>
   <span class="font10">patients: </span>
   <span class="font10">perception </span>
   <span class="font10">phonophobia, </span>
   <span class="font10">positively </span>
   <span class="font10">potentially </span>
   <span class="font10">practice. </span>
   <span class="font10">prednisone </span>
   <span class="font10">preferred </span>
   <span class="font10">probably </span>
   <span class="font10">processes </span>
   <span class="font10">propranolol </span>
   <span class="font10">prospectively </span>
   <span class="font10">reduce </span>
   <span class="font10">release </span>
   <span class="font10">remission </span>
   <span class="font10">require </span>
   <span class="font10">respect </span>
   <span class="font10">respiratory </span>
   <span class="font10">scans </span>
   <span class="font10">school </span>
   <span class="font10">scientific </span>
   <span class="font10">short </span>
   <span class="font10">specifically </span>
   <span class="font10">start </span>
   <span class="font10">state </span>
   <span class="font10">structures </span>
   <span class="font10">technique </span>
   <span class="font10">therapy, </span>
   <span class="font10">thickness </span>
   <span class="font10">tissue </span>
   <span class="font10">travel </span>
   <span class="font10">understanding </span>
   <span class="font10">van </span>
   <span class="font10">visit= </span>
   <span class="font10">–.±., </span>
   <span class="font10">&amp;gt;= </span>
   <span class="font10">():-. </span>
   <span class="font10">(T) </span>
   <span class="font10">(TTH) </span>
   <span class="font10">(ashina@dadlnet.dk) </span>
   <span class="font10">(nVNS) </span>
   <span class="font10">(p=.); </span>
   <span class="font10">(–. </span>
   <span class="font10">.%), </span>
   <span class="font10">.%). </span>
   <span class="font10">.-.) </span>
   <span class="font10">.±., </span>
   <span class="font10">Additionally, </span>
   <span class="font10">Aim </span>
   <span class="font10">Akershus </span>
   <span class="font10">Alberto </span>
   <span class="font10">Alder </span>
   <span class="font10">Ann </span>
   <span class="font10">Anxiety </span>
   <span class="font10">Applied </span>
   <span class="font10">Baseline= </span>
   <span class="font10">Boston, </span>
   <span class="font10">Brussels, </span>
   <span class="font10">Buse </span>
   <span class="font10">CI, </span>
   <span class="font10">CVST </span>
   <span class="font10">Cefalee </span>
   <span class="font10">Cefaly® </span>
   <span class="font10">Charité </span>
   <span class="font10">Cherubino </span>
   <span class="font10">Chiara </span>
   <span class="font10">Claudia </span>
   <span class="font10">Dublin, </span>
   <span class="font10">EM, </span>
   <span class="font10">Emilia, </span>
   <span class="font10">Feng </span>
   <span class="font10">Following </span>
   <span class="font10">Galca </span>
   <span class="font10">Germany </span>
   <span class="font10">Hcy </span>
   <span class="font10">Helsinki </span>
   <span class="font10">Human </span>
   <span class="font10">ICHD-III </span>
   <span class="font10">ID-CM </span>
   <span class="font10">ITT </span>
   <span class="font10">Idiopathic </span>
   <span class="font10">Industries </span>
   <span class="font10">January </span>
   <span class="font10">June </span>
   <span class="font10">Klatt </span>
   <span class="font10">LFEM </span>
   <span class="font10">M-ICHD </span>
   <span class="font10">MHDs/month </span>
   <span class="font10">MSMD, </span>
   <span class="font10">Massimiliano </span>
   <span class="font10">Migraine: </span>
   <span class="font10">Ministry </span>
   <span class="font10">Modena, </span>
   <span class="font10">Netherlands </span>
   <span class="font10">Neurosciences </span>
   <span class="font10">OSA </span>
   <span class="font10">Olesen </span>
   <span class="font10">Osman </span>
   <span class="font10">Pareja </span>
   <span class="font10">Pellesi </span>
   <span class="font10">Pierelli </span>
   <span class="font10">Placebo </span>
   <span class="font10">Policlinico </span>
   <span class="font10">Post </span>
   <span class="font10">Prevention </span>
   <span class="font10">Psychiatric </span>
   <span class="font10">Quality-of-Life </span>
   <span class="font10">Roma, </span>
   <span class="font10">Rome </span>
   <span class="font10">Scientific </span>
   <span class="font10">Services </span>
   <span class="font10">Site </span>
   <span class="font10">Statistical </span>
   <span class="font10">Steiner </span>
   <span class="font10">TPM </span>
   <span class="font10">TTH, </span>
   <span class="font10">Tehran </span>
   <span class="font10">Tepper </span>
   <span class="font10">Tommaso </span>
   <span class="font10">Torre </span>
   <span class="font10">Total </span>
   <span class="font10">USA, </span>
   <span class="font10">Unit. </span>
   <span class="font10">Universitätsmedizin </span>
   <span class="font10">Valladolid, </span>
   <span class="font10">Virginia </span>
   <span class="font10">Voice </span>
   <span class="font10">Work </span>
   <span class="font10">Yalın </span>
   <span class="font10">Yeung </span>
   <span class="font10">abortive </span>
   <span class="font10">affects </span>
   <span class="font10">alcohol </span>
   <span class="font10">alterations </span>
   <span class="font10">amitriptyline </span>
   <span class="font10">amplitude </span>
   <span class="font10">anti-CGRP </span>
   <span class="font10">antibodies </span>
   <span class="font10">appear </span>
   <span class="font10">approaches </span>
   <span class="font10">available. </span>
   <span class="font10">baseline. </span>
   <span class="font10">cannabinoids </span>
   <span class="font10">care. </span>
   <span class="font10">carriers </span>
   <span class="font10">case-control </span>
   <span class="font10">cell </span>
   <span class="font10">cerebellum </span>
   <span class="font10">comparing </span>
   <span class="font10">conditions. </span>
   <span class="font10">consider </span>
   <span class="font10">consisted </span>
   <span class="font10">consists </span>
   <span class="font10">controls, </span>
   <span class="font10">department </span>
   <span class="font10">depression, </span>
   <span class="font10">depression. </span>
   <span class="font10">diagnosis. </span>
   <span class="font10">disabilities </span>
   <span class="font10">discontinued </span>
   <span class="font10">disturbances </span>
   <span class="font10">dorsal </span>
   <span class="font10">edition. </span>
   <span class="font10">education </span>
   <span class="font10">efficacy. </span>
   <span class="font10">endpoint </span>
   <span class="font10">epigenetic </span>
   <span class="font10">examine </span>
   <span class="font10">examined </span>
   <span class="font10">expressed </span>
   <span class="font10">facial </span>
   <span class="font10">facilitation </span>
   <span class="font10">factors, </span>
   <span class="font10">fiber </span>
   <span class="font10">flags </span>
   <span class="font10">follow-up, </span>
   <span class="font10">future </span>
   <span class="font10">generalized </span>
   <span class="font10">generally </span>
   <span class="font10">hand, </span>
   <span class="font10">hormones </span>
   <span class="font10">hours, </span>
   <span class="font10">hypothesis </span>
   <span class="font10">includes </span>
   <span class="font10">indicates </span>
   <span class="font10">intent-to-treat </span>
   <span class="font10">interval, </span>
   <span class="font10">involvement </span>
   <span class="font10">laboratory </span>
   <span class="font10">life. </span>
   <span class="font10">making </span>
   <span class="font10">medications. </span>
   <span class="font10">method </span>
   <span class="font10">migraine-like </span>
   <span class="font10">modified </span>
   <span class="font10">monthly, </span>
   <span class="font10">muscle </span>
   <span class="font10">musculoskeletal </span>
   <span class="font10">nervous </span>
   <span class="font10">nociceptive </span>
   <span class="font10">non-missing </span>
   <span class="font10">normal. </span>
   <span class="font10">numerous </span>
   <span class="font10">observation </span>
   <span class="font10">onset. </span>
   <span class="font10">optimal </span>
   <span class="font10">option </span>
   <span class="font10">perfusion </span>
   <span class="font10">perspective, </span>
   <span class="font10">photophobia, </span>
   <span class="font10">post-traumatic </span>
   <span class="font10">posterior </span>
   <span class="font10">preceding </span>
   <span class="font10">predict </span>
   <span class="font10">prescription </span>
   <span class="font10">presentation </span>
   <span class="font10">proper </span>
   <span class="font10">questionnaires </span>
   <span class="font10">recently </span>
   <span class="font10">reflect </span>
   <span class="font10">reports </span>
   <span class="font10">responded </span>
   <span class="font10">responsible </span>
   <span class="font10">results. </span>
   <span class="font10">score, </span>
   <span class="font10">screener </span>
   <span class="font10">selective </span>
   <span class="font10">sessions </span>
   <span class="font10">severity, </span>
   <span class="font10">sham-controlled </span>
   <span class="font10">significance </span>
   <span class="font10">skin </span>
   <span class="font10">stressful </span>
   <span class="font10">supports </span>
   <span class="font10">surgical </span>
   <span class="font10">survey. </span>
   <span class="font10">systems </span>
   <span class="font10">systems. </span>
   <span class="font10">therapies. </span>
   <span class="font10">transcranial </span>
   <span class="font10">triggers </span>
   <span class="font10">use. </span>
   <span class="font10">volunteers </span>
   <span class="font10">were: </span>
   <span class="font10">wide </span>
   <span class="font10">years). </span>
   <span class="font10"> Change </span>
   <span class="font10">&amp;lt;.). </span>
   <span class="font10">(&amp;lt; </span>
   <span class="font10">(.%)pts, </span>
   <span class="font10">(.%, </span>
   <span class="font10">(.), </span>
   <span class="font10">(AEs) </span>
   <span class="font10">(EVOLVE-); </span>
   <span class="font10">(IS), </span>
   <span class="font10">(N=), </span>
   <span class="font10">(age </span>
   <span class="font10">(all </span>
   <span class="font10">(mean±SEM: </span>
   <span class="font10">(n= </span>
   <span class="font10">(n=, </span>
   <span class="font10">(p&amp;lt;.), </span>
   <span class="font10">(quarterly </span>
   <span class="font10">(with </span>
   <span class="font10">-week, </span>
   <span class="font10">Allodynia </span>
   <span class="font10">Andrew </span>
   <span class="font10">Background. </span>
   <span class="font10">Barbanti </span>
   <span class="font10">Bigal </span>
   <span class="font10">Biomedicine </span>
   <span class="font10">CALCA </span>
   <span class="font10">CBT </span>
   <span class="font10">CM-MO </span>
   <span class="font10">CTE </span>
   <span class="font10">California, </span>
   <span class="font10">Catanzaro, </span>
   <span class="font10">Children’s </span>
   <span class="font10">Clin </span>
   <span class="font10">Compostela, </span>
   <span class="font10">Cortical </span>
   <span class="font10">D., </span>
   <span class="font10">DW, </span>
   <span class="font10">EVOLVE-) </span>
   <span class="font10">Effects </span>
   <span class="font10">Ellipse </span>
   <span class="font10">Ernesto </span>
   <span class="font10">Evans </span>
   <span class="font10">GMB_mg: </span>
   <span class="font10">Giulia </span>
   <span class="font10">Giuseppe </span>
   <span class="font10">GmbH; </span>
   <span class="font10">Group-, </span>
   <span class="font10">HRU </span>
   <span class="font10">Healthcare </span>
   <span class="font10">IIH. </span>
   <span class="font10">Imaging </span>
   <span class="font10">Index </span>
   <span class="font10">Irimia </span>
   <span class="font10">Israel </span>
   <span class="font10">Italy, </span>
   <span class="font10">LCD </span>
   <span class="font10">LLC. </span>
   <span class="font10">Laboratories, </span>
   <span class="font10">Lars </span>
   <span class="font10">Left, </span>
   <span class="font10">Leiden </span>
   <span class="font10">Licia </span>
   <span class="font10">Life </span>
   <span class="font10">MD, </span>
   <span class="font10">MIGRAINE </span>
   <span class="font10">MacGregor </span>
   <span class="font10">Management </span>
   <span class="font10">March </span>
   <span class="font10">Material </span>
   <span class="font10">Medical, </span>
   <span class="font10">Mersin </span>
   <span class="font10">Monthly </span>
   <span class="font10">N=; </span>
   <span class="font10">NADPH </span>
   <span class="font10">Neurologia, </span>
   <span class="font10">Neurosonology </span>
   <span class="font10">Nomigren® </span>
   <span class="font10">Objectives: </span>
   <span class="font10">Oslo, </span>
   <span class="font10">P&amp;lt;.), </span>
   <span class="font10">PA, </span>
   <span class="font10">PAG </span>
   <span class="font10">PRO </span>
   <span class="font10">PTCH </span>
   <span class="font10">Pistoia </span>
   <span class="font10">Polo </span>
   <span class="font10">Pozo-Rosich </span>
   <span class="font10">Pozzilli </span>
   <span class="font10">Prevalence </span>
   <span class="font10">RCTs </span>
   <span class="font10">Reed </span>
   <span class="font10">Reference </span>
   <span class="font10">Right, </span>
   <span class="font10">Romina </span>
   <span class="font10">Ruiz </span>
   <span class="font10">SISC </span>
   <span class="font10">Santa </span>
   <span class="font10">Santiago </span>
   <span class="font10">Score </span>
   <span class="font10">September </span>
   <span class="font10">Silvia </span>
   <span class="font10">Simon </span>
   <span class="font10">Step </span>
   <span class="font10">Stroke </span>
   <span class="font10">Summary </span>
   <span class="font10">Surgical </span>
   <span class="font10">Symptoms </span>
   <span class="font10">TRPA </span>
   <span class="font10">Transcranial </span>
   <span class="font10">Turkey </span>
   <span class="font10">VAS </span>
   <span class="font10">Valeriani </span>
   <span class="font10">Wang </span>
   <span class="font10">accordance </span>
   <span class="font10">acid </span>
   <span class="font10">algorithm </span>
   <span class="font10">allodynia. </span>
   <span class="font10">amitriptyline, </span>
   <span class="font10">analyze </span>
   <span class="font10">aortic </span>
   <span class="font10">attack, </span>
   <span class="font10">aura: </span>
   <span class="font10">baseline; </span>
   <span class="font10">binds </span>
   <span class="font10">blocks </span>
   <span class="font10">carotid </span>
   <span class="font10">cases. </span>
   <span class="font10">characteristic </span>
   <span class="font10">characteristics, </span>
   <span class="font10">children. </span>
   <span class="font10">circumference </span>
   <span class="font10">clinics </span>
   <span class="font10">close </span>
   <span class="font10">code </span>
   <span class="font10">comparisons </span>
   <span class="font10">complained </span>
   <span class="font10">compliance </span>
   <span class="font10">concept </span>
   <span class="font10">contraceptives </span>
   <span class="font10">cord </span>
   <span class="font10">cortex. </span>
   <span class="font10">criteria, </span>
   <span class="font10">currently </span>
   <span class="font10">days/month) </span>
   <span class="font10">description </span>
   <span class="font10">device </span>
   <span class="font10">diet </span>
   <span class="font10">differential </span>
   <span class="font10">diffusion </span>
   <span class="font10">directly </span>
   <span class="font10">disorder, </span>
   <span class="font10">dissection </span>
   <span class="font10">documented </span>
   <span class="font10">domain </span>
   <span class="font10">duration, </span>
   <span class="font10">dysfunctions </span>
   <span class="font10">d’Hebron </span>
   <span class="font10">education, </span>
   <span class="font10">electrical </span>
   <span class="font10">essential </span>
   <span class="font10">estimate </span>
   <span class="font10">ethical </span>
   <span class="font10">evaluated. </span>
   <span class="font10">event </span>
   <span class="font10">executive </span>
   <span class="font10">exhibited </span>
   <span class="font10">exists </span>
   <span class="font10">expected </span>
   <span class="font10">experts </span>
   <span class="font10">explained </span>
   <span class="font10">fat </span>
   <span class="font10">females, </span>
   <span class="font10">financial </span>
   <span class="font10">flow </span>
   <span class="font10">food </span>
   <span class="font10">functioning </span>
   <span class="font10">galcanezumab, </span>
   <span class="font10">galcanezumab-treated </span>
   <span class="font10">ganglion </span>
   <span class="font10">gender, </span>
   <span class="font10">headache-related </span>
   <span class="font10">hemiplegic </span>
   <span class="font10">hypotension </span>
   <span class="font10">idiopathic </span>
   <span class="font10">implicated </span>
   <span class="font10">implications </span>
   <span class="font10">improvements </span>
   <span class="font10">indicating </span>
   <span class="font10">infection, </span>
   <span class="font10">interval </span>
   <span class="font10">lived </span>
   <span class="font10">localization </span>
   <span class="font10">magnesium </span>
   <span class="font10">males, </span>
   <span class="font10">management. </span>
   <span class="font10">mechanical </span>
   <span class="font10">metabolic </span>
   <span class="font10">million </span>
   <span class="font10">molecular </span>
   <span class="font10">necessary </span>
   <span class="font10">neuroimaging </span>
   <span class="font10">neurologic </span>
   <span class="font10">nociceptors </span>
   <span class="font10">novel </span>
   <span class="font10">nutraceuticals </span>
   <span class="font10">p=., </span>
   <span class="font10">pain-free </span>
   <span class="font10">parents </span>
   <span class="font10">participate </span>
   <span class="font10">plasma </span>
   <span class="font10">post-baseline </span>
   <span class="font10">post-treatment </span>
   <span class="font10">principal </span>
   <span class="font10">process </span>
   <span class="font10">prognosis </span>
   <span class="font10">progressive </span>
   <span class="font10">px; </span>
   <span class="font10">question </span>
   <span class="font10">questions </span>
   <span class="font10">ranging </span>
   <span class="font10">rates, </span>
   <span class="font10">reactivity </span>
   <span class="font10">recall </span>
   <span class="font10">recommended </span>
   <span class="font10">reference </span>
   <span class="font10">regarding </span>
   <span class="font10">regions </span>
   <span class="font10">relationships </span>
   <span class="font10">reliable </span>
   <span class="font10">remain </span>
   <span class="font10">resolution </span>
   <span class="font10">reveal </span>
   <span class="font10">reversible </span>
   <span class="font10">reviewed </span>
   <span class="font10">safety, </span>
   <span class="font10">setting </span>
   <span class="font10">sham, </span>
   <span class="font10">specialist </span>
   <span class="font10">stable </span>
   <span class="font10">steroid </span>
   <span class="font10">stop </span>
   <span class="font10">structural </span>
   <span class="font10">subject </span>
   <span class="font10">subjective </span>
   <span class="font10">subsequent </span>
   <span class="font10">successful </span>
   <span class="font10">sufficient </span>
   <span class="font10">supplement </span>
   <span class="font10">them, </span>
   <span class="font10">therapies, </span>
   <span class="font10">thrombosis </span>
   <span class="font10">toxin </span>
   <span class="font10">training </span>
   <span class="font10">unique </span>
   <span class="font10">utility </span>
   <span class="font10">world </span>
   <span class="font10">yielded </span>
   <span class="font10">{font-family </span>
   <span class="font10">Özgür </span>
   <span class="font10">(CH) </span>
   <span class="font10">(EVOLVE- </span>
   <span class="font10">(HIT-) </span>
   <span class="font10">(NCT). </span>
   <span class="font10">(PBO) </span>
   <span class="font10">(Spearman </span>
   <span class="font10">(T: </span>
   <span class="font10">(for </span>
   <span class="font10">(n=). </span>
   <span class="font10">(nVNS, </span>
   <span class="font10">-). </span>
   <span class="font10">-mg=.; </span>
   <span class="font10">.%a </span>
   <span class="font10">/). </span>
   <span class="font10">;:. </span>
   <span class="font10">ARNAS </span>
   <span class="font10">Abuse </span>
   <span class="font10">Adverse </span>
   <span class="font10">Again, </span>
   <span class="font10">Altamura </span>
   <span class="font10">Amgen, </span>
   <span class="font10">Amgen; </span>
   <span class="font10">Angela </span>
   <span class="font10">Annik </span>
   <span class="font10">BTX-A </span>
   <span class="font10">Basking </span>
   <span class="font10">Blumenfeld </span>
   <span class="font10">Body </span>
   <span class="font10">Brandes </span>
   <span class="font10">CH, </span>
   <span class="font10">Case </span>
   <span class="font10">Clinico </span>
   <span class="font10">Comorbidities </span>
   <span class="font10">Company </span>
   <span class="font10">DBF </span>
   <span class="font10">December </span>
   <span class="font10">EHF </span>
   <span class="font10">ESA </span>
   <span class="font10">Elisa </span>
   <span class="font10">Elizabeth </span>
   <span class="font10">Evaluation </span>
   <span class="font10">External </span>
   <span class="font10">F., </span>
   <span class="font10">Ferrari </span>
   <span class="font10">Filippo </span>
   <span class="font10">Finally, </span>
   <span class="font10">García-Azorín </span>
   <span class="font10">Gaul </span>
   <span class="font10">Geppetti </span>
   <span class="font10">German </span>
   <span class="font10">Group. </span>
   <span class="font10">Groups: </span>
   <span class="font10">HIT </span>
   <span class="font10">Headache: </span>
   <span class="font10">ISR-AEs </span>
   <span class="font10">IT-EC-ID </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">Iran; </span>
   <span class="font10">Ireland, </span>
   <span class="font10">Jes </span>
   <span class="font10">Kingdom; </span>
   <span class="font10">LJ, </span>
   <span class="font10">LP-ICP </span>
   <span class="font10">Lanfranco </span>
   <span class="font10">Lanteri-Minet </span>
   <span class="font10">Latina, </span>
   <span class="font10">Leiden, </span>
   <span class="font10">ML, </span>
   <span class="font10">MTBI </span>
   <span class="font10">Magna </span>
   <span class="font10">Manack </span>
   <span class="font10">Manjit </span>
   <span class="font10">Matharu </span>
   <span class="font10">Mersin, </span>
   <span class="font10">Michela </span>
   <span class="font10">Movement </span>
   <span class="font10">MwA </span>
   <span class="font10">MwoA </span>
   <span class="font10">NCT) </span>
   <span class="font10">NH, </span>
   <span class="font10">NHWS </span>
   <span class="font10">NRS </span>
   <span class="font10">NRX </span>
   <span class="font10">Neck </span>
   <span class="font10">Neurologia </span>
   <span class="font10">Neurology. </span>
   <span class="font10">North </span>
   <span class="font10">Outcomes </span>
   <span class="font10">Overall </span>
   <span class="font10">Oxford </span>
   <span class="font10">PACNS </span>
   <span class="font10">Papetti </span>
   <span class="font10">Paris, </span>
   <span class="font10">Parisi </span>
   <span class="font10">Pearlman </span>
   <span class="font10">Pfizer </span>
   <span class="font10">Physical </span>
   <span class="font10">Pierangeli </span>
   <span class="font10">Pontino, </span>
   <span class="font10">Preventive </span>
   <span class="font10">Prof. </span>
   <span class="font10">RB, </span>
   <span class="font10">RESULTS </span>
   <span class="font10">Rep. </span>
   <span class="font10">Ridge, </span>
   <span class="font10">Roberto </span>
   <span class="font10">Russo </span>
   <span class="font10">S., </span>
   <span class="font10">SAMURAI </span>
   <span class="font10">Sabrina </span>
   <span class="font10">Salvatore </span>
   <span class="font10">Sances </span>
   <span class="font10">Sarah </span>
   <span class="font10">Schoenen </span>
   <span class="font10">Schwedt </span>
   <span class="font10">Scienze </span>
   <span class="font10">Society, </span>
   <span class="font10">Spanish </span>
   <span class="font10">State </span>
   <span class="font10">Sumatriptan </span>
   <span class="font10">Systems </span>
   <span class="font10">TMS </span>
   <span class="font10">TOT </span>
   <span class="font10">Therapeutic </span>
   <span class="font10">Therapy </span>
   <span class="font10">Thus, </span>
   <span class="font10">Timothy </span>
   <span class="font10">Type </span>
   <span class="font10">Visual </span>
   <span class="font10">[-]. </span>
   <span class="font10">abuse </span>
   <span class="font10">acting </span>
   <span class="font10">activate </span>
   <span class="font10">adequate </span>
   <span class="font10">allowed </span>
   <span class="font10">angiography </span>
   <span class="font10">annual </span>
   <span class="font10">anterior </span>
   <span class="font10">applicability </span>
   <span class="font10">areas. </span>
   <span class="font10">assessments </span>
   <span class="font10">assuming </span>
   <span class="font10">available, </span>
   <span class="font10">behalf </span>
   <span class="font10">behavioral </span>
   <span class="font10">block </span>
   <span class="font10">cases, </span>
   <span class="font10">causal </span>
   <span class="font10">cephalic </span>
   <span class="font10">characteristics. </span>
   <span class="font10">collaboration </span>
   <span class="font10">comparable </span>
   <span class="font10">connectivity </span>
   <span class="font10">consent. </span>
   <span class="font10">consequence </span>
   <span class="font10">considering </span>
   <span class="font10">consultant </span>
   <span class="font10">contribute </span>
   <span class="font10">correlates </span>
   <span class="font10">cycles </span>
   <span class="font10">decision </span>
   <span class="font10">define </span>
   <span class="font10">delle </span>
   <span class="font10">department, </span>
   <span class="font10">descriptive </span>
   <span class="font10">detected </span>
   <span class="font10">diagnose </span>
   <span class="font10">discussed </span>
   <span class="font10">diseases, </span>
   <span class="font10">distance </span>
   <span class="font10">domains </span>
   <span class="font10">dosage </span>
   <span class="font10">dropout </span>
   <span class="font10">dynamic </span>
   <span class="font10">efficacy, </span>
   <span class="font10">endpoints </span>
   <span class="font10">entire </span>
   <span class="font10">epidural </span>
   <span class="font10">error </span>
   <span class="font10">established </span>
   <span class="font10">exception </span>
   <span class="font10">excitatory </span>
   <span class="font10">exogenous </span>
   <span class="font10">experiences </span>
   <span class="font10">false </span>
   <span class="font10">far </span>
   <span class="font10">feasibility </span>
   <span class="font10">features, </span>
   <span class="font10">filled </span>
   <span class="font10">firing </span>
   <span class="font10">font-size </span>
   <span class="font10">foods </span>
   <span class="font10">freedom </span>
   <span class="font10">full-time </span>
   <span class="font10">functioning, </span>
   <span class="font10">grade </span>
   <span class="font10">guidelines. </span>
   <span class="font10">hallodynia </span>
   <span class="font10">highlighted </span>
   <span class="font10">highlights </span>
   <span class="font10">importance </span>
   <span class="font10">improvement. </span>
   <span class="font10">included: </span>
   <span class="font10">increasingly </span>
   <span class="font10">infection </span>
   <span class="font10">interviews </span>
   <span class="font10">intracortical </span>
   <span class="font10">involving </span>
   <span class="font10">it. </span>
   <span class="font10">item </span>
   <span class="font10">limit </span>
   <span class="font10">link </span>
   <span class="font10">literature. </span>
   <span class="font10">living </span>
   <span class="font10">location </span>
   <span class="font10">lowest </span>
   <span class="font10">make </span>
   <span class="font10">marked </span>
   <span class="font10">maximal </span>
   <span class="font10">measurements </span>
   <span class="font10">measures. </span>
   <span class="font10">migraine/probable </span>
   <span class="font10">minor </span>
   <span class="font10">missed </span>
   <span class="font10">month), </span>
   <span class="font10">mutations </span>
   <span class="font10">nausea, </span>
   <span class="font10">nicotine </span>
   <span class="font10">non </span>
   <span class="font10">noted </span>
   <span class="font10">options. </span>
   <span class="font10">outside </span>
   <span class="font10">ownership </span>
   <span class="font10">parallel-group </span>
   <span class="font10">participants. </span>
   <span class="font10">pathology </span>
   <span class="font10">pathway </span>
   <span class="font10">peptides </span>
   <span class="font10">periventricular </span>
   <span class="font10">pharmaceutical </span>
   <span class="font10">pivotal </span>
   <span class="font10">placebo) </span>
   <span class="font10">placebo: </span>
   <span class="font10">plant </span>
   <span class="font10">plasticity </span>
   <span class="font10">plus </span>
   <span class="font10">population-based </span>
   <span class="font10">populations </span>
   <span class="font10">pre-existing </span>
   <span class="font10">predictive </span>
   <span class="font10">prevention. </span>
   <span class="font10">problem </span>
   <span class="font10">programs </span>
   <span class="font10">promising </span>
   <span class="font10">proportions </span>
   <span class="font10">protective </span>
   <span class="font10">rapid </span>
   <span class="font10">rarely </span>
   <span class="font10">ratios </span>
   <span class="font10">real-world </span>
   <span class="font10">reason </span>
   <span class="font10">recurrence </span>
   <span class="font10">refer </span>
   <span class="font10">referring </span>
   <span class="font10">regardless </span>
   <span class="font10">region. </span>
   <span class="font10">relative </span>
   <span class="font10">relevance </span>
   <span class="font10">rescue </span>
   <span class="font10">response, </span>
   <span class="font10">samples </span>
   <span class="font10">sensitive </span>
   <span class="font10">serotonin </span>
   <span class="font10">services </span>
   <span class="font10">severity. </span>
   <span class="font10">short-term </span>
   <span class="font10">societal </span>
   <span class="font10">starting </span>
   <span class="font10">stiffness </span>
   <span class="font10">stimulations </span>
   <span class="font10">structure </span>
   <span class="font10">survey, </span>
   <span class="font10">susceptibility </span>
   <span class="font10">system, </span>
   <span class="font10">tDCS </span>
   <span class="font10">targeting </span>
   <span class="font10">techniques </span>
   <span class="font10">test. </span>
   <span class="font10">tested </span>
   <span class="font10">text </span>
   <span class="font10">tightening </span>
   <span class="font10">time, </span>
   <span class="font10">transmission </span>
   <span class="font10">treatments, </span>
   <span class="font10">triggered </span>
   <span class="font10">triptans. </span>
   <span class="font10">typical </span>
   <span class="font10">university </span>
   <span class="font10">unknown. </span>
   <span class="font10">validated </span>
   <span class="font10">vaping </span>
   <span class="font10">variability </span>
   <span class="font10">vasoconstriction </span>
   <span class="font10">vasodilation </span>
   <span class="font10">version). </span>
   <span class="font10">vertigo </span>
   <span class="font10">way </span>
   <span class="font10">weak </span>
   <span class="font10"> Baseline </span>
   <span class="font10">–.±.; </span>
   <span class="font10">(&amp;gt; </span>
   <span class="font10">(-), </span>
   <span class="font10">(CI </span>
   <span class="font10">(ClinicalTrials.gov, </span>
   <span class="font10">(ICHD- </span>
   <span class="font10">(MIDAS), </span>
   <span class="font10">(Spearman’s </span>
   <span class="font10">(at </span>
   <span class="font10">(from </span>
   <span class="font10">(higher </span>
   <span class="font10">(i.e., </span>
   <span class="font10">(including </span>
   <span class="font10">(number </span>
   <span class="font10">(p&amp;lt; </span>
   <span class="font10">(range: </span>
   <span class="font10">(reduction </span>
   <span class="font10">(–) </span>
   <span class="font10">(−. </span>
   <span class="font10">,±,%, </span>
   <span class="font10">.-., </span>
   <span class="font10">;():–. </span>
   <span class="font10">A., </span>
   <span class="font10">ANOVA </span>
   <span class="font10">APOE </span>
   <span class="font10">Activity </span>
   <span class="font10">Athens, </span>
   <span class="font10">Aubrey </span>
   <span class="font10">Audrey </span>
   <span class="font10">Aurastop </span>
   <span class="font10">Aurora, </span>
   <span class="font10">Aycardi </span>
   <span class="font10">Belgium </span>
   <span class="font10">Beth </span>
   <span class="font10">Biomedical </span>
   <span class="font10">Biotechnologies, </span>
   <span class="font10">Biotechnology, </span>
   <span class="font10">Board, </span>
   <span class="font10">Bono </span>
   <span class="font10">Botox </span>
   <span class="font10">CI) </span>
   <span class="font10">COMPEL </span>
   <span class="font10">CONCLUSION: </span>
   <span class="font10">CSD. </span>
   <span class="font10">Campos </span>
   <span class="font10">Carlos, </span>
   <span class="font10">Carolei </span>
   <span class="font10">Cerrahpasa </span>
   <span class="font10">Cevoli </span>
   <span class="font10">Cheng </span>
   <span class="font10">Clínica </span>
   <span class="font10">Compared </span>
   <span class="font10">Craven </span>
   <span class="font10">Cutaneous </span>
   <span class="font10">César </span>
   <span class="font10">DC, </span>
   <span class="font10">Dawn </span>
   <span class="font10">Deaconess </span>
   <span class="font10">Demonte </span>
   <span class="font10">Dept. </span>
   <span class="font10">Derya </span>
   <span class="font10">Despite </span>
   <span class="font10">Diagnosis </span>
   <span class="font10">Dietetics, </span>
   <span class="font10">Dipartimento </span>
   <span class="font10">Domenico </span>
   <span class="font10">Don </span>
   <span class="font10">Donna </span>
   <span class="font10">Duisburg-Essen, </span>
   <span class="font10">Dumas </span>
   <span class="font10">Dustin </span>
   <span class="font10">EBP </span>
   <span class="font10">Early </span>
   <span class="font10">Economics </span>
   <span class="font10">Epidemiology, </span>
   <span class="font10">Eur </span>
   <span class="font10">Europe, </span>
   <span class="font10">February </span>
   <span class="font10">Fernández-de-las-Peñas </span>
   <span class="font10">Fierro </span>
   <span class="font10">Fondazione </span>
   <span class="font10">Further, </span>
   <span class="font10">Future </span>
   <span class="font10">G.B. </span>
   <span class="font10">Giovanni </span>
   <span class="font10">Good </span>
   <span class="font10">Graecia </span>
   <span class="font10">Granato </span>
   <span class="font10">Guy’s </span>
   <span class="font10">HRQoL </span>
   <span class="font10">Hans-Christoph </span>
   <span class="font10">Harvard </span>
   <span class="font10">Head </span>
   <span class="font10">Health. </span>
   <span class="font10">ICHD-, </span>
   <span class="font10">IDAP </span>
   <span class="font10">Injection </span>
   <span class="font10">Investigación </span>
   <span class="font10">Iranian </span>
   <span class="font10">Istanbul, </span>
   <span class="font10">James </span>
   <span class="font10">Jeffrey </span>
   <span class="font10">Jersey, </span>
   <span class="font10">Jessica </span>
   <span class="font10">Katsarava </span>
   <span class="font10">Key </span>
   <span class="font10">King's </span>
   <span class="font10">Literature </span>
   <span class="font10">Liège, </span>
   <span class="font10">Louise </span>
   <span class="font10">Luca </span>
   <span class="font10">M., </span>
   <span class="font10">MEDICAL </span>
   <span class="font10">METHODS </span>
   <span class="font10">MO, </span>
   <span class="font10">MRMHDs </span>
   <span class="font10">Main </span>
   <span class="font10">Matteo </span>
   <span class="font10">Med </span>
   <span class="font10">Medico-Surgical </span>
   <span class="font10">Meeting </span>
   <span class="font10">Messina </span>
   <span class="font10">Michele </span>
   <span class="font10">Migraine, </span>
   <span class="font10">Mitsikostas </span>
   <span class="font10">Mollan </span>
   <span class="font10">NCT). </span>
   <span class="font10">NJ, </span>
   <span class="font10">NR- </span>
   <span class="font10">NSAIDs </span>
   <span class="font10">Nasal </span>
   <span class="font10">Nerve </span>
   <span class="font10">Nevertheless, </span>
   <span class="font10">Novartis, </span>
   <span class="font10">November </span>
   <span class="font10">Nutrition </span>
   <span class="font10">OBJECTIVES: </span>
   <span class="font10">Occipital </span>
   <span class="font10">October </span>
   <span class="font10">Oral </span>
   <span class="font10">Organization </span>
   <span class="font10">P=.). </span>
   <span class="font10">PAC </span>
   <span class="font10">PBO: </span>
   <span class="font10">PDH </span>
   <span class="font10">PHQ- </span>
   <span class="font10">PTC </span>
   <span class="font10">Participants </span>
   <span class="font10">Petolicchio </span>
   <span class="font10">Pharma; </span>
   <span class="font10">Pharmaceuticals; </span>
   <span class="font10">Pharmacology, </span>
   <span class="font10">Physicians </span>
   <span class="font10">Positive </span>
   <span class="font10">Pressing </span>
   <span class="font10">Previous </span>
   <span class="font10">Princiotta </span>
   <span class="font10">Productivity </span>
   <span class="font10">Prophylactic </span>
   <span class="font10">Psychiatry </span>
   <span class="font10">Psychology, </span>
   <span class="font10">QOL </span>
   <span class="font10">Rainero </span>
   <span class="font10">Rapisarda </span>
   <span class="font10">Rasmussen </span>
   <span class="font10">Reductions </span>
   <span class="font10">Registration: </span>
   <span class="font10">Rehabilitation </span>
   <span class="font10">Responders </span>
   <span class="font10">RoI </span>
   <span class="font10">Rotterdam, </span>
   <span class="font10">Russell </span>
   <span class="font10">SIH </span>
   <span class="font10">SPARTAN </span>
   <span class="font10">STRIVE </span>
   <span class="font10">Sara </span>
   <span class="font10">Section </span>
   <span class="font10">Serum </span>
   <span class="font10">Significant </span>
   <span class="font10">Similarly, </span>
   <span class="font10">Social </span>
   <span class="font10">Spain, </span>
   <span class="font10">Square, </span>
   <span class="font10">Stauffer </span>
   <span class="font10">Stovner </span>
   <span class="font10">Sunfa </span>
   <span class="font10">TAWH </span>
   <span class="font10">TIA. </span>
   <span class="font10">Tarantino </span>
   <span class="font10">Teva, </span>
   <span class="font10">The </span>
   <span class="font10">Throbbing </span>
   <span class="font10">Todd </span>
   <span class="font10">Traitement </span>
   <span class="font10">Trigeminal </span>
   <span class="font10">Turkish </span>
   <span class="font10">Universitari </span>
   <span class="font10">Uzuner </span>
   <span class="font10">Vascular </span>
   <span class="font10">Vision </span>
   <span class="font10">WB, </span>
   <span class="font10">WMH </span>
   <span class="font10">White </span>
   <span class="font10">Yes, </span>
   <span class="font10">Yuju </span>
   <span class="font10">abstract </span>
   <span class="font10">acceptable </span>
   <span class="font10">accompanying </span>
   <span class="font10">act </span>
   <span class="font10">actions </span>
   <span class="font10">addiction </span>
   <span class="font10">addition </span>
   <span class="font10">adjusted </span>
   <span class="font10">admittance </span>
   <span class="font10">alexithymia </span>
   <span class="font10">alternative </span>
   <span class="font10">anthropometric </span>
   <span class="font10">anti-allodynic </span>
   <span class="font10">applying </span>
   <span class="font10">assumed </span>
   <span class="font10">avoid </span>
   <span class="font10">basilar </span>
   <span class="font10">behaviour </span>
   <span class="font10">benefits </span>
   <span class="font10">best </span>
   <span class="font10">biological </span>
   <span class="font10">both, </span>
   <span class="font10">botulinum </span>
   <span class="font10">bout </span>
   <span class="font10">brain. </span>
   <span class="font10">cells, </span>
   <span class="font10">cervicogenic </span>
   <span class="font10">channels </span>
   <span class="font10">chapter </span>
   <span class="font10">child </span>
   <span class="font10">chronic) </span>
   <span class="font10">cingulate </span>
   <span class="font10">clear </span>
   <span class="font10">clemastine </span>
   <span class="font10">clinical, </span>
   <span class="font10">coherence </span>
   <span class="font10">collection </span>
   <span class="font10">company </span>
   <span class="font10">component </span>
   <span class="font10">compound </span>
   <span class="font10">consistently </span>
   <span class="font10">consulting </span>
   <span class="font10">contributed </span>
   <span class="font10">conversion </span>
   <span class="font10">coronary </span>
   <span class="font10">correlations </span>
   <span class="font10">corresponding </span>
   <span class="font10">cortex, </span>
   <span class="font10">countries, </span>
   <span class="font10">critical </span>
   <span class="font10">cumulative </span>
   <span class="font10">date </span>
   <span class="font10">day. </span>
   <span class="font10">delivered </span>
   <span class="font10">despite </span>
   <span class="font10">detection </span>
   <span class="font10">diagnoses </span>
   <span class="font10">diagnosis, </span>
   <span class="font10">distributed </span>
   <span class="font10">dizziness </span>
   <span class="font10">dopaminergic </span>
   <span class="font10">dose. </span>
   <span class="font10">double; </span>
   <span class="font10">drug. </span>
   <span class="font10">duration. </span>
   <span class="font10">eTNS </span>
   <span class="font10">effective. </span>
   <span class="font10">effects. </span>
   <span class="font10">efficacious </span>
   <span class="font10">efficient </span>
   <span class="font10">electrophysiological </span>
   <span class="font10">employees </span>
   <span class="font10">entered </span>
   <span class="font10">error]: </span>
   <span class="font10">excluded </span>
   <span class="font10">exertion </span>
   <span class="font10">expenditure </span>
   <span class="font10">expert </span>
   <span class="font10">exposed </span>
   <span class="font10">familial </span>
   <span class="font10">fatty </span>
   <span class="font10">feature </span>
   <span class="font10">flash </span>
   <span class="font10">form, </span>
   <span class="font10">generic </span>
   <span class="font10">genomic </span>
   <span class="font10">glucose </span>
   <span class="font10">goal </span>
   <span class="font10">great </span>
   <span class="font10">growing </span>
   <span class="font10">heterogeneous </span>
   <span class="font10">home </span>
   <span class="font10">hours. </span>
   <span class="font10">hypertension. </span>
   <span class="font10">identification </span>
   <span class="font10">immediately </span>
   <span class="font10">incidence, </span>
   <span class="font10">inclusion </span>
   <span class="font10">index, </span>
   <span class="font10">inhibits </span>
   <span class="font10">injuries </span>
   <span class="font10">innovative </span>
   <span class="font10">input </span>
   <span class="font10">intake. </span>
   <span class="font10">interests </span>
   <span class="font10">iron </span>
   <span class="font10">language </span>
   <span class="font10">late </span>
   <span class="font10">led </span>
   <span class="font10">life, </span>
   <span class="font10">likelihood </span>
   <span class="font10">line </span>
   <span class="font10">little </span>
   <span class="font10">localized </span>
   <span class="font10">maintenance </span>
   <span class="font10">male, </span>
   <span class="font10">medications, </span>
   <span class="font10">mentioned </span>
   <span class="font10">met </span>
   <span class="font10">mg), </span>
   <span class="font10">mg; </span>
   <span class="font10">modulation </span>
   <span class="font10">molecules </span>
   <span class="font10">month). </span>
   <span class="font10">months) </span>
   <span class="font10">months). </span>
   <span class="font10">movements </span>
   <span class="font10">multidisciplinary </span>
   <span class="font10">muscles </span>
   <span class="font10">natural </span>
   <span class="font10">negatively </span>
   <span class="font10">neuralgia, </span>
   <span class="font10">neurology </span>
   <span class="font10">notice? </span>
   <span class="font10">nuclei </span>
   <span class="font10">nucleus </span>
   <span class="font10">observations </span>
   <span class="font10">occupational </span>
   <span class="font10">ongoing </span>
   <span class="font10">opinion </span>
   <span class="font10">outcomes, </span>
   <span class="font10">ovarian </span>
   <span class="font10">ownership. </span>
   <span class="font10">parent </span>
   <span class="font10">parietal </span>
   <span class="font10">patent </span>
   <span class="font10">patient, </span>
   <span class="font10">patient’s </span>
   <span class="font10">patterns </span>
   <span class="font10">perceived </span>
   <span class="font10">percent </span>
   <span class="font10">percentages </span>
   <span class="font10">peripapillary </span>
   <span class="font10">persons </span>
   <span class="font10">pharmacy </span>
   <span class="font10">phase. </span>
   <span class="font10">phenomena </span>
   <span class="font10">plays </span>
   <span class="font10">politicians </span>
   <span class="font10">premonitory </span>
   <span class="font10">prevalence, </span>
   <span class="font10">preventing </span>
   <span class="font10">problems </span>
   <span class="font10">procedures </span>
   <span class="font10">productive </span>
   <span class="font10">prognostic </span>
   <span class="font10">prolonged </span>
   <span class="font10">providing </span>
   <span class="font10">psychotherapy </span>
   <span class="font10">questionnaires. </span>
   <span class="font10">quintile </span>
   <span class="font10">rat </span>
   <span class="font10">rate, </span>
   <span class="font10">real-life </span>
   <span class="font10">reasons </span>
   <span class="font10">records </span>
   <span class="font10">regimens </span>
   <span class="font10">reliability </span>
   <span class="font10">relief </span>
   <span class="font10">respectively) </span>
   <span class="font10">scores, </span>
   <span class="font10">scores. </span>
   <span class="font10">selection </span>
   <span class="font10">seven </span>
   <span class="font10">signs </span>
   <span class="font10">simultaneously </span>
   <span class="font10">sites </span>
   <span class="font10">sites. </span>
   <span class="font10">smokers </span>
   <span class="font10">socio-demographic </span>
   <span class="font10">sociodemographic </span>
   <span class="font10">software </span>
   <span class="font10">status, </span>
   <span class="font10">step </span>
   <span class="font10">strategies </span>
   <span class="font10">strategy </span>
   <span class="font10">stress </span>
   <span class="font10">strictly </span>
   <span class="font10">strong </span>
   <span class="font10">studies; </span>
   <span class="font10">subcutaneously </span>
   <span class="font10">subset </span>
   <span class="font10">supine </span>
   <span class="font10">supplementation </span>
   <span class="font10">supraorbital </span>
   <span class="font10">suspected </span>
   <span class="font10">taking </span>
   <span class="font10">technology </span>
   <span class="font10">them. </span>
   <span class="font10">thought </span>
   <span class="font10">thresholds </span>
   <span class="font10">thrombophilic </span>
   <span class="font10">thunderclap </span>
   <span class="font10">tomography </span>
   <span class="font10">trauma. </span>
   <span class="font10">traumas </span>
   <span class="font10">trial. </span>
   <span class="font10">trials. </span>
   <span class="font10">two-year </span>
   <span class="font10">typically </span>
   <span class="font10">univariate </span>
   <span class="font10">utilization </span>
   <span class="font10">velocity </span>
   <span class="font10">verify </span>
   <span class="font10">vessel </span>
   <span class="font10">visit, </span>
   <span class="font10">vital </span>
   <span class="font10">woman </span>
   <span class="font10">year. </span>
   <span class="font10">years), </span>
   <span class="font10">  - </span>
   <span class="font10">€,. </span>
   <span class="font10">(), </span>
   <span class="font10">(,%). </span>
   <span class="font10">(-). </span>
   <span class="font10">(.); </span>
   <span class="font10">(::) </span>
   <span class="font10">(CSD) </span>
   <span class="font10">(FFQ) </span>
   <span class="font10">(MA) </span>
   <span class="font10">(MIDAS) </span>
   <span class="font10">(MO) </span>
   <span class="font10">(MRI) </span>
   <span class="font10">(MSMD), </span>
   <span class="font10">(OR=., </span>
   <span class="font10">(Phase </span>
   <span class="font10">(SD </span>
   <span class="font10">(VHIR), </span>
   <span class="font10">(both </span>
   <span class="font10">(davilink@hotmail.com) </span>
   <span class="font10">(gianluca.coppola@gmail.com) </span>
   <span class="font10">(in </span>
   <span class="font10">(nVNS; </span>
   <span class="font10">(see </span>
   <span class="font10">(the </span>
   <span class="font10">(≥% </span>
   <span class="font10">-hour </span>
   <span class="font10">-hydroxyvitamin </span>
   <span class="font10">-year-old </span>
   <span class="font10">.%c </span>
   <span class="font10">.-.%). </span>
   <span class="font10">.-.). </span>
   <span class="font10">.]; </span>
   <span class="font10">.±.; </span>
   <span class="font10">AMY </span>
   <span class="font10">APOA </span>
   <span class="font10">ASST </span>
   <span class="font10">ATP </span>
   <span class="font10">Aalborg </span>
   <span class="font10">Action, </span>
   <span class="font10">Adams </span>
   <span class="font10">Africa, </span>
   <span class="font10">Alder, </span>
   <span class="font10">Ali </span>
   <span class="font10">America, </span>
   <span class="font10">Amitriptyline </span>
   <span class="font10">Annette </span>
   <span class="font10">Annual </span>
   <span class="font10">Appointment </span>
   <span class="font10">Area </span>
   <span class="font10">Associate </span>
   <span class="font10">Associations, </span>
   <span class="font10">Atlas </span>
   <span class="font10">B., </span>
   <span class="font10">Baraldi </span>
   <span class="font10">Bari </span>
   <span class="font10">Bari, </span>
   <span class="font10">Basic </span>
   <span class="font10">Belgrade, </span>
   <span class="font10">Benemei </span>
   <span class="font10">BiTox </span>
   <span class="font10">Bietti </span>
   <span class="font10">Bio-Medico </span>
   <span class="font10">Biohaven, </span>
   <span class="font10">Biostatistics </span>
   <span class="font10">Board. </span>
   <span class="font10">Boehringer </span>
   <span class="font10">Bosnia </span>
   <span class="font10">British </span>
   <span class="font10">Burstein </span>
   <span class="font10">Bussone </span>
   <span class="font10">CaMEO </span>
   <span class="font10">Cannabinoids </span>
   <span class="font10">Carboni </span>
   <span class="font10">Catanzaro </span>
   <span class="font10">Centre. </span>
   <span class="font10">Christian </span>
   <span class="font10">Città </span>
   <span class="font10">Civico </span>
   <span class="font10">Class </span>
   <span class="font10">Cochrane </span>
   <span class="font10">Cognitive </span>
   <span class="font10">Combined </span>
   <span class="font10">Commission </span>
   <span class="font10">Communications, </span>
   <span class="font10">Complete </span>
   <span class="font10">Conclusion. </span>
   <span class="font10">Congress </span>
   <span class="font10">Consortium </span>
   <span class="font10">Corporation, </span>
   <span class="font10">Correlation </span>
   <span class="font10">Cosentino </span>
   <span class="font10">Council </span>
   <span class="font10">Critical </span>
   <span class="font10">Curelator </span>
   <span class="font10">DBP </span>
   <span class="font10">Dalla </span>
   <span class="font10">Dartmouth, </span>
   <span class="font10">Della </span>
   <span class="font10">Diamond </span>
   <span class="font10">Different </span>
   <span class="font10">Discussion. </span>
   <span class="font10">Division, </span>
   <span class="font10">Douleur, </span>
   <span class="font10">Ducros </span>
   <span class="font10">Duration </span>
   <span class="font10">Département </span>
   <span class="font10">EHF; </span>
   <span class="font10">EM. </span>
   <span class="font10">East </span>
   <span class="font10">Education, </span>
   <span class="font10">Epilepsy </span>
   <span class="font10">Erasmus </span>
   <span class="font10">Essen, </span>
   <span class="font10">Fabrizio </span>
   <span class="font10">Fink </span>
   <span class="font10">Fiorin </span>
   <span class="font10">Fitzgerald </span>
   <span class="font10">Follow-up </span>
   <span class="font10">Ford </span>
   <span class="font10">France </span>
   <span class="font10">France, </span>
   <span class="font10">GFK, </span>
   <span class="font10">GON-B </span>
   <span class="font10">Galcanezumab, </span>
   <span class="font10">Geisel </span>
   <span class="font10">Germany. </span>
   <span class="font10">GfK </span>
   <span class="font10">Greco </span>
   <span class="font10">Greece </span>
   <span class="font10">Greece; </span>
   <span class="font10">Guerrero </span>
   <span class="font10">Guerzoni </span>
   <span class="font10">Guidetti </span>
   <span class="font10">Hashmat </span>
   <span class="font10">HealthSOAF </span>
   <span class="font10">Heart </span>
   <span class="font10">Henrik </span>
   <span class="font10">Hospitalo-Universitaire </span>
   <span class="font10">IHS </span>
   <span class="font10">ISDN </span>
   <span class="font10">Impairment </span>
   <span class="font10">Intractable </span>
   <span class="font10">Ireland; </span>
   <span class="font10">Irene </span>
   <span class="font10">Isabel </span>
   <span class="font10">Janet </span>
   <span class="font10">Jean </span>
   <span class="font10">Jennifer </span>
   <span class="font10">Juan </span>
   <span class="font10">Jul;():-. </span>
   <span class="font10">Kharkiv </span>
   <span class="font10">Kristen </span>
   <span class="font10">L., </span>
   <span class="font10">LCP </span>
   <span class="font10">Lambru </span>
   <span class="font10">Lampl </span>
   <span class="font10">Leeds </span>
   <span class="font10">Leicester, </span>
   <span class="font10">Leonardi </span>
   <span class="font10">ME, </span>
   <span class="font10">MHDs/ </span>
   <span class="font10">MOH, </span>
   <span class="font10">MPFID-PI </span>
   <span class="font10">MRI, </span>
   <span class="font10">MTT </span>
   <span class="font10">Mainardi </span>
   <span class="font10">Maja </span>
   <span class="font10">Mansoureh </span>
   <span class="font10">Marchese </span>
   <span class="font10">Martin </span>
   <span class="font10">Metabolic </span>
   <span class="font10">Method: </span>
   <span class="font10">Milano; </span>
   <span class="font10">Moscow, </span>
   <span class="font10">Nappi </span>
   <span class="font10">Navarra, </span>
   <span class="font10">Neuroimaging </span>
   <span class="font10">Neurologic </span>
   <span class="font10">Neurologist </span>
   <span class="font10">Neurologists </span>
   <span class="font10">Neuromedicine </span>
   <span class="font10">Neuromodulation </span>
   <span class="font10">Neurophthalmology, </span>
   <span class="font10">Neurophysiology, </span>
   <span class="font10">Neuropsichiatry </span>
   <span class="font10">Non </span>
   <span class="font10">Non-invasive </span>
   <span class="font10">Nummular </span>
   <span class="font10">Outcome </span>
   <span class="font10">Outpatient </span>
   <span class="font10">P&amp;lt;. </span>
   <span class="font10">P&amp;lt;.; </span>
   <span class="font10">PCA </span>
   <span class="font10">PFO. </span>
   <span class="font10">PREMIUM </span>
   <span class="font10">PRES </span>
   <span class="font10">PREVA </span>
   <span class="font10">Padova, </span>
   <span class="font10">Padua, </span>
   <span class="font10">Parameter </span>
   <span class="font10">Participants’ </span>
   <span class="font10">Patricia </span>
   <span class="font10">Pavia; </span>
   <span class="font10">People </span>
   <span class="font10">Persistent </span>
   <span class="font10">Perugia, </span>
   <span class="font10">Pharma, </span>
   <span class="font10">Pini </span>
   <span class="font10">Practice </span>
   <span class="font10">Prakash </span>
   <span class="font10">Pucci </span>
   <span class="font10">Puma </span>
   <span class="font10">Quintana </span>
   <span class="font10">RCVS, </span>
   <span class="font10">RCVS. </span>
   <span class="font10">REGAIN, </span>
   <span class="font10">Rachel </span>
   <span class="font10">Radiology, </span>
   <span class="font10">Ramirez </span>
   <span class="font10">Rebeca </span>
   <span class="font10">Rebecchi </span>
   <span class="font10">Region </span>
   <span class="font10">Retinal </span>
   <span class="font10">Rey </span>
   <span class="font10">Ribbe </span>
   <span class="font10">Rigmor </span>
   <span class="font10">Risk </span>
   <span class="font10">Roberta </span>
   <span class="font10">Roma </span>
   <span class="font10">Royal </span>
   <span class="font10">Russia; </span>
   <span class="font10">S-L </span>
   <span class="font10">Sarchielli </span>
   <span class="font10">Schytz </span>
   <span class="font10">Scottsdale, </span>
   <span class="font10">Services, </span>
   <span class="font10">Severity </span>
   <span class="font10">Silva-Néto </span>
   <span class="font10">Society. </span>
   <span class="font10">Sophie </span>
   <span class="font10">Specific </span>
   <span class="font10">Spontaneous </span>
   <span class="font10">Springer </span>
   <span class="font10">Stabbing </span>
   <span class="font10">Stefano </span>
   <span class="font10">Stella </span>
   <span class="font10">Stephanie </span>
   <span class="font10">Studies </span>
   <span class="font10">Study. </span>
   <span class="font10">Sweden </span>
   <span class="font10">Symptom </span>
   <span class="font10">TCZ </span>
   <span class="font10">TJ, </span>
   <span class="font10">Tanacethum </span>
   <span class="font10">Teresa </span>
   <span class="font10">Thomas’ </span>
   <span class="font10">Time </span>
   <span class="font10">Tinelli </span>
   <span class="font10">Tirana, </span>
   <span class="font10">Togha </span>
   <span class="font10">Trieste, </span>
   <span class="font10">UOC </span>
   <span class="font10">Uludüz </span>
   <span class="font10">Universitat </span>
   <span class="font10">VEP </span>
   <span class="font10">VIP </span>
   <span class="font10">Valencia, </span>
   <span class="font10">Valentina </span>
   <span class="font10">Vangaa </span>
   <span class="font10">Vedanta </span>
   <span class="font10">Verena </span>
   <span class="font10">Vernieri </span>
   <span class="font10">Veruska </span>
   <span class="font10">Vestibular </span>
   <span class="font10">Viana </span>
   <span class="font10">Viganò </span>
   <span class="font10">Vos </span>
   <span class="font10">WML </span>
   <span class="font10">WPAI </span>
   <span class="font10">Walsh </span>
   <span class="font10">West </span>
   <span class="font10">Zanchin </span>
   <span class="font10">[,,]. </span>
   <span class="font10">[., </span>
   <span class="font10">[.], </span>
   <span class="font10">[n=], </span>
   <span class="font10">aPLs </span>
   <span class="font10">accompanied </span>
   <span class="font10">achieve </span>
   <span class="font10">acutely </span>
   <span class="font10">administration, </span>
   <span class="font10">admission </span>
   <span class="font10">affinity </span>
   <span class="font10">ages </span>
   <span class="font10">aims </span>
   <span class="font10">allodynia, </span>
   <span class="font10">allows </span>
   <span class="font10">alter </span>
   <span class="font10">angle </span>
   <span class="font10">anonymity </span>
   <span class="font10">antagonist </span>
   <span class="font10">apnea </span>
   <span class="font10">appeared </span>
   <span class="font10">appendix </span>
   <span class="font10">attacks/week; </span>
   <span class="font10">attended </span>
   <span class="font10">attending </span>
   <span class="font10">balance </span>
   <span class="font10">basal </span>
   <span class="font10">basic </span>
   <span class="font10">beginning </span>
   <span class="font10">billion </span>
   <span class="font10">biomarkers </span>
   <span class="font10">boards </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">brain, </span>
   <span class="font10">burden. </span>
   <span class="font10">captured </span>
   <span class="font10">carbohydrate </span>
   <span class="font10">case, </span>
   <span class="font10">category </span>
   <span class="font10">centers </span>
   <span class="font10">cephalalgic </span>
   <span class="font10">cerebellar </span>
   <span class="font10">cerebrovascular </span>
   <span class="font10">challenging </span>
   <span class="font10">children, </span>
   <span class="font10">chronification. </span>
   <span class="font10">clinic. </span>
   <span class="font10">clinicians </span>
   <span class="font10">comparative </span>
   <span class="font10">comprised </span>
   <span class="font10">concentrations, </span>
   <span class="font10">concerning </span>
   <span class="font10">confidentially </span>
   <span class="font10">consequences </span>
   <span class="font10">consulted </span>
   <span class="font10">contributions </span>
   <span class="font10">control. </span>
   <span class="font10">covariance </span>
   <span class="font10">crucial </span>
   <span class="font10">cytokines </span>
   <span class="font10">debilitating </span>
   <span class="font10">decade </span>
   <span class="font10">deficit </span>
   <span class="font10">definite </span>
   <span class="font10">den </span>
   <span class="font10">detect </span>
   <span class="font10">development. </span>
   <span class="font10">disclose. </span>
   <span class="font10">discuss </span>
   <span class="font10">disruption </span>
   <span class="font10">double </span>
   <span class="font10">drugs, </span>
   <span class="font10">d’Evaluation </span>
   <span class="font10">eCH </span>
   <span class="font10">educational </span>
   <span class="font10">efficiency </span>
   <span class="font10">elevated </span>
   <span class="font10">employed </span>
   <span class="font10">encourage </span>
   <span class="font10">enrolled. </span>
   <span class="font10">establish </span>
   <span class="font10">estimates </span>
   <span class="font10">estrogen </span>
   <span class="font10">etiology </span>
   <span class="font10">events. </span>
   <span class="font10">evidence-based </span>
   <span class="font10">exacerbation </span>
   <span class="font10">exploratory </span>
   <span class="font10">extracellular </span>
   <span class="font10">extremely </span>
   <span class="font10">fact </span>
   <span class="font10">failures </span>
   <span class="font10">fees, </span>
   <span class="font10">female. </span>
   <span class="font10">field </span>
   <span class="font10">finding </span>
   <span class="font10">flashes </span>
   <span class="font10">fluctuations </span>
   <span class="font10">fold </span>
   <span class="font10">foramen </span>
   <span class="font10">frequency. </span>
   <span class="font10">fulfilling </span>
   <span class="font10">funding </span>
   <span class="font10">gain </span>
   <span class="font10">galcanezumab. </span>
   <span class="font10">ganglia </span>
   <span class="font10">genes </span>
   <span class="font10">glial </span>
   <span class="font10">globally </span>
   <span class="font10">glycemic </span>
   <span class="font10">gold </span>
   <span class="font10">gray </span>
   <span class="font10">handled </span>
   <span class="font10">history, </span>
   <span class="font10">hyperintensities </span>
   <span class="font10">hypothalamic </span>
   <span class="font10">immune </span>
   <span class="font10">impairment, </span>
   <span class="font10">improving </span>
   <span class="font10">inflammation, </span>
   <span class="font10">inflammation. </span>
   <span class="font10">influenced </span>
   <span class="font10">infusion. </span>
   <span class="font10">inner </span>
   <span class="font10">insomnia </span>
   <span class="font10">instrument </span>
   <span class="font10">intake, </span>
   <span class="font10">integrated </span>
   <span class="font10">interim </span>
   <span class="font10">intervals </span>
   <span class="font10">intravenous </span>
   <span class="font10">involves </span>
   <span class="font10">ipsilateral </span>
   <span class="font10">itself </span>
   <span class="font10">larger </span>
   <span class="font10">largest </span>
   <span class="font10">layer, </span>
   <span class="font10">layers </span>
   <span class="font10">lecture </span>
   <span class="font10">level. </span>
   <span class="font10">levels. </span>
   <span class="font10">light </span>
   <span class="font10">limb </span>
   <span class="font10">loading </span>
   <span class="font10">located </span>
   <span class="font10">longitudinal </span>
   <span class="font10">low, </span>
   <span class="font10">macrophages </span>
   <span class="font10">marital </span>
   <span class="font10">markers </span>
   <span class="font10">mast </span>
   <span class="font10">matching </span>
   <span class="font10">max </span>
   <span class="font10">maximum </span>
   <span class="font10">measurement </span>
   <span class="font10">mediators </span>
   <span class="font10">metabolism </span>
   <span class="font10">migraine; </span>
   <span class="font10">migraine? </span>
   <span class="font10">migraines </span>
   <span class="font10">migraineurs. </span>
   <span class="font10">moderate/severe </span>
   <span class="font10">moderately </span>
   <span class="font10">modulating </span>
   <span class="font10">movement </span>
   <span class="font10">multicenter </span>
   <span class="font10">nerves </span>
   <span class="font10">neurogenic </span>
   <span class="font10">neurologist </span>
   <span class="font10">neurons. </span>
   <span class="font10">neurosarcoidosis </span>
   <span class="font10">neurostimulation </span>
   <span class="font10">nosographic </span>
   <span class="font10">not. </span>
   <span class="font10">nuclear </span>
   <span class="font10">nummular </span>
   <span class="font10">occurrence, </span>
   <span class="font10">ocular </span>
   <span class="font10">ones </span>
   <span class="font10">opportunity </span>
   <span class="font10">organizations. </span>
   <span class="font10">originate </span>
   <span class="font10">overused </span>
   <span class="font10">p&amp;gt;.). </span>
   <span class="font10">p&amp;lt;,). </span>
   <span class="font10">panels </span>
   <span class="font10">paroxysmal </span>
   <span class="font10">particular, </span>
   <span class="font10">pathogenetic </span>
   <span class="font10">periods </span>
   <span class="font10">perivascular </span>
   <span class="font10">persistence </span>
   <span class="font10">perspectives </span>
   <span class="font10">pharmacist </span>
   <span class="font10">phase, </span>
   <span class="font10">phone </span>
   <span class="font10">postural </span>
   <span class="font10">potentials </span>
   <span class="font10">practical </span>
   <span class="font10">pre-injury </span>
   <span class="font10">predicted </span>
   <span class="font10">predicting </span>
   <span class="font10">predictor </span>
   <span class="font10">pretreatment </span>
   <span class="font10">primarily </span>
   <span class="font10">probability </span>
   <span class="font10">processed </span>
   <span class="font10">production </span>
   <span class="font10">profiles </span>
   <span class="font10">program. </span>
   <span class="font10">propensity </span>
   <span class="font10">protocol. </span>
   <span class="font10">providers </span>
   <span class="font10">publications </span>
   <span class="font10">purposes. </span>
   <span class="font10">quantitative </span>
   <span class="font10">quarterly, </span>
   <span class="font10">questionnaire. </span>
   <span class="font10">random </span>
   <span class="font10">ranged </span>
   <span class="font10">rated </span>
   <span class="font10">reached </span>
   <span class="font10">recording </span>
   <span class="font10">regards </span>
   <span class="font10">repetitive </span>
   <span class="font10">representing </span>
   <span class="font10">reproductive </span>
   <span class="font10">requires </span>
   <span class="font10">resources </span>
   <span class="font10">respond </span>
   <span class="font10">results, </span>
   <span class="font10">return </span>
   <span class="font10">reverted </span>
   <span class="font10">rho=., </span>
   <span class="font10">rotation </span>
   <span class="font10">run-in </span>
   <span class="font10">saline </span>
   <span class="font10">scales </span>
   <span class="font10">screened </span>
   <span class="font10">search </span>
   <span class="font10">self-administered </span>
   <span class="font10">self-reported </span>
   <span class="font10">separate </span>
   <span class="font10">separation </span>
   <span class="font10">setting. </span>
   <span class="font10">sex </span>
   <span class="font10">sex, </span>
   <span class="font10">share </span>
   <span class="font10">sick </span>
   <span class="font10">signal </span>
   <span class="font10">signs, </span>
   <span class="font10">similarities </span>
   <span class="font10">sinus </span>
   <span class="font10">size </span>
   <span class="font10">slight </span>
   <span class="font10">slightly </span>
   <span class="font10">so-called </span>
   <span class="font10">solid; </span>
   <span class="font10">sought </span>
   <span class="font10">source </span>
   <span class="font10">specialists. </span>
   <span class="font10">standardized </span>
   <span class="font10">starts </span>
   <span class="font10">stepwise </span>
   <span class="font10">stimulation. </span>
   <span class="font10">stocks. </span>
   <span class="font10">stopped </span>
   <span class="font10">stroke, </span>
   <span class="font10">studying </span>
   <span class="font10">subarachnoid </span>
   <span class="font10">subjects, </span>
   <span class="font10">substance </span>
   <span class="font10">subtypes </span>
   <span class="font10">susceptible </span>
   <span class="font10">symptom: </span>
   <span class="font10">tDCS-Group </span>
   <span class="font10">tablet </span>
   <span class="font10">targeted </span>
   <span class="font10">tend </span>
   <span class="font10">tenderness </span>
   <span class="font10">test, </span>
   <span class="font10">tests, </span>
   <span class="font10">tests. </span>
   <span class="font10">tissues, </span>
   <span class="font10">took </span>
   <span class="font10">treatment-emergent </span>
   <span class="font10">trend </span>
   <span class="font10">trials, </span>
   <span class="font10">type. </span>
   <span class="font10">ultrasound </span>
   <span class="font10">uncontrolled </span>
   <span class="font10">unknown </span>
   <span class="font10">unremitting </span>
   <span class="font10">usual </span>
   <span class="font10">validation </span>
   <span class="font10">validity </span>
   <span class="font10">valproate </span>
   <span class="font10">value; </span>
   <span class="font10">varied </span>
   <span class="font10">visits, </span>
   <span class="font10">vivo </span>
   <span class="font10">waves </span>
   <span class="font10">weeks. </span>
   <span class="font10">well. </span>
   <span class="font10">withdrawal. </span>
   <span class="font10">x-min </span>
   <span class="font10">year, </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10"> Average </span>
   <span class="font10"> Difference </span>
   <span class="font10">−.; </span>
   <span class="font10">≥%, </span>
   <span class="font10">"C. </span>
   <span class="font10">"Overweight" </span>
   <span class="font10">%), </span>
   <span class="font10">&amp;amp;; </span>
   <span class="font10">&amp;lt;.); </span>
   <span class="font10">(,%) </span>
   <span class="font10">(.%; </span>
   <span class="font10">(.). </span>
   <span class="font10">(..), </span>
   <span class="font10">(BMI) </span>
   <span class="font10">(BioNeC), </span>
   <span class="font10">(Botox®) </span>
   <span class="font10">(CM), </span>
   <span class="font10">(CM: </span>
   <span class="font10">(EBC) </span>
   <span class="font10">(EHF) </span>
   <span class="font10">(EM). </span>
   <span class="font10">(ICHD-) </span>
   <span class="font10">(Investigator), </span>
   <span class="font10">(MIDAS </span>
   <span class="font10">(MOH). </span>
   <span class="font10">(Migraine </span>
   <span class="font10">(NCT </span>
   <span class="font10">(NDPH) </span>
   <span class="font10">(NRS </span>
   <span class="font10">(PEA) </span>
   <span class="font10">(Study </span>
   <span class="font10">(Suppl </span>
   <span class="font10">(V. </span>
   <span class="font10">(c.altamura@unicampus.it) </span>
   <span class="font10">(frequency, </span>
   <span class="font10">(group </span>
   <span class="font10">(n=; </span>
   <span class="font10">(on </span>
   <span class="font10">(onabotA, </span>
   <span class="font10">(osmanozguryalin@yahoo.com) </span>
   <span class="font10">(paolo.martelletti@uniroma.it) </span>
   <span class="font10">(quarterly, </span>
   <span class="font10">(r=., </span>
   <span class="font10">(sTMS) </span>
   <span class="font10">(simona.sacco@univaq.it) </span>
   <span class="font10">(two </span>
   <span class="font10">(years) </span>
   <span class="font10">-), </span>
   <span class="font10">-,; </span>
   <span class="font10">-months </span>
   <span class="font10">-point </span>
   <span class="font10">-second </span>
   <span class="font10">-times </span>
   <span class="font10">.(.) </span>
   <span class="font10">.±.SD </span>
   <span class="font10">:–. </span>
   <span class="font10">;():. </span>
   <span class="font10">;:- </span>
   <span class="font10">;:–. </span>
   <span class="font10">ADM_ </span>
   <span class="font10">AE, </span>
   <span class="font10">AIM-D </span>
   <span class="font10">AM, </span>
   <span class="font10">Aalborg, </span>
   <span class="font10">Abbreviations: </span>
   <span class="font10">Abnormal </span>
   <span class="font10">Administration </span>
   <span class="font10">Aires, </span>
   <span class="font10">Al-Karagholi </span>
   <span class="font10">Alba, </span>
   <span class="font10">Alcorcón, </span>
   <span class="font10">Alessandra </span>
   <span class="font10">Alessandro </span>
   <span class="font10">Alexithymia </span>
   <span class="font10">Algology </span>
   <span class="font10">Alliance, </span>
   <span class="font10">Almirall, </span>
   <span class="font10">Also, </span>
   <span class="font10">Ambrosini </span>
   <span class="font10">Ameri </span>
   <span class="font10">Ana </span>
   <span class="font10">Andrea </span>
   <span class="font10">Andreou </span>
   <span class="font10">Anesthesia, </span>
   <span class="font10">Angelo </span>
   <span class="font10">April </span>
   <span class="font10">Arbor, </span>
   <span class="font10">Asia </span>
   <span class="font10">Attack </span>
   <span class="font10">Australia; </span>
   <span class="font10">Avanir </span>
   <span class="font10">Avanir, </span>
   <span class="font10">Aynur </span>
   <span class="font10">BACKGROUND </span>
   <span class="font10">BID </span>
   <span class="font10">Battan </span>
   <span class="font10">Battan, </span>
   <span class="font10">Begasse </span>
   <span class="font10">Bendtsen </span>
   <span class="font10">Benhaddi </span>
   <span class="font10">Besta" </span>
   <span class="font10">BioPharmaceuticals </span>
   <span class="font10">Bonferroni </span>
   <span class="font10">Boston </span>
   <span class="font10">Box </span>
   <span class="font10">Brescia, </span>
   <span class="font10">Brunelli, </span>
   <span class="font10">Brusa </span>
   <span class="font10">Budapest, </span>
   <span class="font10">Buenos </span>
   <span class="font10">Burden. </span>
   <span class="font10">CADASIL </span>
   <span class="font10">CGRP. </span>
   <span class="font10">CHRONIC </span>
   <span class="font10">CM-MOH </span>
   <span class="font10">CONCLUSIONS </span>
   <span class="font10">CPH </span>
   <span class="font10">Cambridge </span>
   <span class="font10">Canada, </span>
   <span class="font10">Capital </span>
   <span class="font10">Cariddi, </span>
   <span class="font10">Carles </span>
   <span class="font10">Carmela </span>
   <span class="font10">Casper </span>
   <span class="font10">Castaldo </span>
   <span class="font10">Catholic </span>
   <span class="font10">Cecchi, </span>
   <span class="font10">Cefalee, </span>
   <span class="font10">Center. </span>
   <span class="font10">Characteristics </span>
   <span class="font10">Charly </span>
   <span class="font10">Chi-square </span>
   <span class="font10">Christensen </span>
   <span class="font10">Cinzia </span>
   <span class="font10">City, </span>
   <span class="font10">Columbia </span>
   <span class="font10">Controls </span>
   <span class="font10">Conversely, </span>
   <span class="font10">Correpondence: </span>
   <span class="font10">Cowan </span>
   <span class="font10">Cox </span>
   <span class="font10">Criteria </span>
   <span class="font10">Czech </span>
   <span class="font10">DADO </span>
   <span class="font10">DDIs </span>
   <span class="font10">DTI </span>
   <span class="font10">Daily </span>
   <span class="font10">Database </span>
   <span class="font10">Demographic </span>
   <span class="font10">Deparment </span>
   <span class="font10">Departamento </span>
   <span class="font10">Departments </span>
   <span class="font10">Dependence </span>
   <span class="font10">Diary </span>
   <span class="font10">Dip. </span>
   <span class="font10">Diseases </span>
   <span class="font10">Disorder </span>
   <span class="font10">Dominguez </span>
   <span class="font10">Doppler </span>
   <span class="font10">Dresden, </span>
   <span class="font10">ETT </span>
   <span class="font10">Economic </span>
   <span class="font10">Effectiveness </span>
   <span class="font10">ElectroCore </span>
   <span class="font10">Eleonora </span>
   <span class="font10">Elisabetta </span>
   <span class="font10">Emil </span>
   <span class="font10">England </span>
   <span class="font10">Epidemiology </span>
   <span class="font10">Ertsey </span>
   <span class="font10">Evangelista </span>
   <span class="font10">Exposure-adjusted </span>
   <span class="font10">FAAH </span>
   <span class="font10">FFTx </span>
   <span class="font10">FFTy </span>
   <span class="font10">Facial </span>
   <span class="font10">Factors </span>
   <span class="font10">Family </span>
   <span class="font10">Female: </span>
   <span class="font10">Fisioterapia, </span>
   <span class="font10">Florence </span>
   <span class="font10">Foundation. </span>
   <span class="font10">Frequency </span>
   <span class="font10">Functional </span>
   <span class="font10">GAD- </span>
   <span class="font10">GMB_mg </span>
   <span class="font10">Gabriella </span>
   <span class="font10">Gambardella </span>
   <span class="font10">Gentile </span>
   <span class="font10">Gesù </span>
   <span class="font10">Ghanizada </span>
   <span class="font10">Ghiotto </span>
   <span class="font10">Ghorbani </span>
   <span class="font10">Given </span>
   <span class="font10">Group-: </span>
   <span class="font10">HCP </span>
   <span class="font10">Hansen </span>
   <span class="font10">Hemicrania </span>
   <span class="font10">Herzegovina; </span>
   <span class="font10">Hicham </span>
   <span class="font10">High </span>
   <span class="font10">History </span>
   <span class="font10">Hormonal </span>
   <span class="font10">Hormosan </span>
   <span class="font10">Hôpital </span>
   <span class="font10">ICA </span>
   <span class="font10">ICHD-II </span>
   <span class="font10">ID-M </span>
   <span class="font10">III </span>
   <span class="font10">Iannacchero </span>
   <span class="font10">Icco </span>
   <span class="font10">Incidence </span>
   <span class="font10">Independent </span>
   <span class="font10">India </span>
   <span class="font10">Individuals </span>
   <span class="font10">Informatics, </span>
   <span class="font10">Innocenzo </span>
   <span class="font10">Innsbruck, </span>
   <span class="font10">Institutes </span>
   <span class="font10">JA. </span>
   <span class="font10">Jahromi </span>
   <span class="font10">Javier </span>
   <span class="font10">Joan </span>
   <span class="font10">Jones </span>
   <span class="font10">Joseph </span>
   <span class="font10">K.-Laflamme </span>
   <span class="font10">KDs </span>
   <span class="font10">Kantar </span>
   <span class="font10">Keywords: </span>
   <span class="font10">Khan </span>
   <span class="font10">Lancet </span>
   <span class="font10">Lenght </span>
   <span class="font10">Levi </span>
   <span class="font10">Linde </span>
   <span class="font10">Lisotto </span>
   <span class="font10">Liverpool, </span>
   <span class="font10">Lloyd </span>
   <span class="font10">Location </span>
   <span class="font10">Logistic </span>
   <span class="font10">London; </span>
   <span class="font10">Lucia </span>
   <span class="font10">Luise </span>
   <span class="font10">Lørenskog; </span>
   <span class="font10">MCA </span>
   <span class="font10">MDX </span>
   <span class="font10">MHDs, </span>
   <span class="font10">MPFID-EA </span>
   <span class="font10">MRA </span>
   <span class="font10">MRI. </span>
   <span class="font10">MSQ-EF </span>
   <span class="font10">MSQ-RFR </span>
   <span class="font10">Magis </span>
   <span class="font10">Magnetic </span>
   <span class="font10">Male: </span>
   <span class="font10">Marcelo </span>
   <span class="font10">Mark </span>
   <span class="font10">María </span>
   <span class="font10">Massachusetts </span>
   <span class="font10">Massachusetts, </span>
   <span class="font10">Matilde </span>
   <span class="font10">Matter </span>
   <span class="font10">McAllister </span>
   <span class="font10">Med. </span>
   <span class="font10">Medicina </span>
   <span class="font10">Mehmet </span>
   <span class="font10">Meningeal </span>
   <span class="font10">Mia </span>
   <span class="font10">Michigan, </span>
   <span class="font10">Minen </span>
   <span class="font10">Moavero </span>
   <span class="font10">Moavero, </span>
   <span class="font10">Mohammad </span>
   <span class="font10">Mona </span>
   <span class="font10">Montefiore </span>
   <span class="font10">Months </span>
   <span class="font10">Multiple </span>
   <span class="font10">Munich, </span>
   <span class="font10">Musculoskeletal </span>
   <span class="font10">NOM-S </span>
   <span class="font10">Nashville </span>
   <span class="font10">Nashville, </span>
   <span class="font10">Negro </span>
   <span class="font10">Network </span>
   <span class="font10">Neurologiche </span>
   <span class="font10">Nicoletta </span>
   <span class="font10">Nicolodi </span>
   <span class="font10">OLE, </span>
   <span class="font10">ONS </span>
   <span class="font10">OSA. </span>
   <span class="font10">Occupational </span>
   <span class="font10">Ocupacional, </span>
   <span class="font10">Onset </span>
   <span class="font10">Open </span>
   <span class="font10">Organs, </span>
   <span class="font10">Orsay, </span>
   <span class="font10">Oslo </span>
   <span class="font10">Osmophobia </span>
   <span class="font10">P&amp;lt;., </span>
   <span class="font10">P., </span>
   <span class="font10">P.O. </span>
   <span class="font10">P=. </span>
   <span class="font10">PA. </span>
   <span class="font10">PAs </span>
   <span class="font10">PCS </span>
   <span class="font10">PEA </span>
   <span class="font10">PGA </span>
   <span class="font10">PT: </span>
   <span class="font10">Pablo </span>
   <span class="font10">Paolucci, </span>
   <span class="font10">Papetti, </span>
   <span class="font10">Parthenium, </span>
   <span class="font10">Past </span>
   <span class="font10">Patent </span>
   <span class="font10">Perfusion </span>
   <span class="font10">Peripapillary </span>
   <span class="font10">Personal </span>
   <span class="font10">Pfizer, </span>
   <span class="font10">Physiology, </span>
   <span class="font10">Pilati </span>
   <span class="font10">Pisana, </span>
   <span class="font10">Possible </span>
   <span class="font10">Post-hoc </span>
   <span class="font10">Practice, </span>
   <span class="font10">Prague </span>
   <span class="font10">Prague, </span>
   <span class="font10">Presentation </span>
   <span class="font10">Project </span>
   <span class="font10">Prospective </span>
   <span class="font10">Qualitative </span>
   <span class="font10">Rating </span>
   <span class="font10">Razeghi </span>
   <span class="font10">Recent </span>
   <span class="font10">Recurrent </span>
   <span class="font10">Rehabilitación </span>
   <span class="font10">Report </span>
   <span class="font10">Republic; </span>
   <span class="font10">Rho= </span>
   <span class="font10">Ricci </span>
   <span class="font10">Right </span>
   <span class="font10">Rigshospitalet, </span>
   <span class="font10">Rigshospitalet-Glostrup, </span>
   <span class="font10">RoM </span>
   <span class="font10">Robbins </span>
   <span class="font10">Rosaria </span>
   <span class="font10">Rosario </span>
   <span class="font10">Rosich </span>
   <span class="font10">Rossi </span>
   <span class="font10">Rozen </span>
   <span class="font10">Rubino </span>
   <span class="font10">Ruff, </span>
   <span class="font10">Russia, </span>
   <span class="font10">SAE </span>
   <span class="font10">SAFA-D </span>
   <span class="font10">SCP </span>
   <span class="font10">SHSs </span>
   <span class="font10">SICI </span>
   <span class="font10">SK, </span>
   <span class="font10">SSDI </span>
   <span class="font10">Saint </span>
   <span class="font10">Salute </span>
   <span class="font10">Samaira </span>
   <span class="font10">Sandoval </span>
   <span class="font10">Sanitaria </span>
   <span class="font10">Scott </span>
   <span class="font10">Searches </span>
   <span class="font10">Semmelweis </span>
   <span class="font10">Sensory </span>
   <span class="font10">Serrano </span>
   <span class="font10">Service, </span>
   <span class="font10">Servicio </span>
   <span class="font10">Seven </span>
   <span class="font10">Sex </span>
   <span class="font10">Sforza </span>
   <span class="font10">Sham-Group </span>
   <span class="font10">Silver </span>
   <span class="font10">Similar </span>
   <span class="font10">Simmaco </span>
   <span class="font10">Sinclair </span>
   <span class="font10">Single </span>
   <span class="font10">Sonia </span>
   <span class="font10">Soodeh </span>
   <span class="font10">Southern </span>
   <span class="font10">Spain. </span>
   <span class="font10">Spreading </span>
   <span class="font10">St. </span>
   <span class="font10">Stanford </span>
   <span class="font10">States; </span>
   <span class="font10">Stockholm, </span>
   <span class="font10">Straube </span>
   <span class="font10">Stroke. </span>
   <span class="font10">Subjects </span>
   <span class="font10">Surface </span>
   <span class="font10">Survey </span>
   <span class="font10">Susan </span>
   <span class="font10">Sustained </span>
   <span class="font10">Sway </span>
   <span class="font10">Sweden; </span>
   <span class="font10">Syndrome </span>
   <span class="font10">System, </span>
   <span class="font10">TAS- </span>
   <span class="font10">TCA </span>
   <span class="font10">TH, </span>
   <span class="font10">TPM, </span>
   <span class="font10">TUR; </span>
   <span class="font10">Tarantino, </span>
   <span class="font10">Technologies, </span>
   <span class="font10">Temporal </span>
   <span class="font10">Terapia </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Thirteen </span>
   <span class="font10">Topiramate </span>
   <span class="font10">Tor </span>
   <span class="font10">Torino, </span>
   <span class="font10">Tosto </span>
   <span class="font10">Tot= </span>
   <span class="font10">Translational </span>
   <span class="font10">Trauma </span>
   <span class="font10">Treatment-by-subgroup </span>
   <span class="font10">Treatment-emergent </span>
   <span class="font10">Trials </span>
   <span class="font10">Trochlear </span>
   <span class="font10">Understanding </span>
   <span class="font10">Value </span>
   <span class="font10">Vanadia </span>
   <span class="font10">Velocity </span>
   <span class="font10">Vergata </span>
   <span class="font10">Vigevano </span>
   <span class="font10">Vollesen </span>
   <span class="font10">Volta </span>
   <span class="font10">Volume </span>
   <span class="font10">Walton </span>
   <span class="font10">Washington, </span>
   <span class="font10">Whitney </span>
   <span class="font10">York </span>
   <span class="font10">Younis </span>
   <span class="font10">Zeinab </span>
   <span class="font10">Zhang, </span>
   <span class="font10">[%], </span>
   <span class="font10">[.]). </span>
   <span class="font10">[least-squares </span>
   <span class="font10">abnormalities, </span>
   <span class="font10">abnormality </span>
   <span class="font10">accepted </span>
   <span class="font10">accessed </span>
   <span class="font10">accessible </span>
   <span class="font10">accuracy </span>
   <span class="font10">accurate </span>
   <span class="font10">acids </span>
   <span class="font10">activity, </span>
   <span class="font10">actual </span>
   <span class="font10">add-on </span>
   <span class="font10">adenomas </span>
   <span class="font10">adults. </span>
   <span class="font10">affecting </span>
   <span class="font10">age:. </span>
   <span class="font10">agreed </span>
   <span class="font10">agreement </span>
   <span class="font10">alteration </span>
   <span class="font10">alternating </span>
   <span class="font10">analyse </span>
   <span class="font10">analyses, </span>
   <span class="font10">analyzed. </span>
   <span class="font10">anatomical </span>
   <span class="font10">angina </span>
   <span class="font10">anodic </span>
   <span class="font10">answer </span>
   <span class="font10">antagonists </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">antiphospholipid </span>
   <span class="font10">anxiety, </span>
   <span class="font10">apart </span>
   <span class="font10">applicable </span>
   <span class="font10">area, </span>
   <span class="font10">areas, </span>
   <span class="font10">arousal </span>
   <span class="font10">assessed. </span>
   <span class="font10">assessing </span>
   <span class="font10">associative </span>
   <span class="font10">atogepant </span>
   <span class="font10">atypical </span>
   <span class="font10">autoimmune </span>
   <span class="font10">axial </span>
   <span class="font10">barrier </span>
   <span class="font10">barriers </span>
   <span class="font10">behavior </span>
   <span class="font10">belief </span>
   <span class="font10">believed </span>
   <span class="font10">beneficial </span>
   <span class="font10">beta-blockers </span>
   <span class="font10">bilaterally </span>
   <span class="font10">bleeding </span>
   <span class="font10">board. </span>
   <span class="font10">bold </span>
   <span class="font10">bolus </span>
   <span class="font10">branches </span>
   <span class="font10">brief </span>
   <span class="font10">bring </span>
   <span class="font10">brought </span>
   <span class="font10">cCH </span>
   <span class="font10">calculated. </span>
   <span class="font10">canonical </span>
   <span class="font10">capsaicin </span>
   <span class="font10">career </span>
   <span class="font10">cellular </span>
   <span class="font10">centers. </span>
   <span class="font10">centres </span>
   <span class="font10">challenge </span>
   <span class="font10">changes, </span>
   <span class="font10">choice </span>
   <span class="font10">classes </span>
   <span class="font10">clearly </span>
   <span class="font10">closely </span>
   <span class="font10">coded </span>
   <span class="font10">cohort. </span>
   <span class="font10">collaborative </span>
   <span class="font10">comorbidities, </span>
   <span class="font10">complaining </span>
   <span class="font10">components </span>
   <span class="font10">compounds </span>
   <span class="font10">concerns </span>
   <span class="font10">conclude </span>
   <span class="font10">concluded </span>
   <span class="font10">conclusion </span>
   <span class="font10">conclusion, </span>
   <span class="font10">conduct </span>
   <span class="font10">connective </span>
   <span class="font10">consecutively </span>
   <span class="font10">consultation </span>
   <span class="font10">contact </span>
   <span class="font10">containing </span>
   <span class="font10">context </span>
   <span class="font10">continua </span>
   <span class="font10">contraceptive </span>
   <span class="font10">contrast </span>
   <span class="font10">contribution </span>
   <span class="font10">controlled, </span>
   <span class="font10">corpalgia </span>
   <span class="font10">correctly </span>
   <span class="font10">cost-effective </span>
   <span class="font10">costs. </span>
   <span class="font10">country </span>
   <span class="font10">courier; </span>
   <span class="font10">created </span>
   <span class="font10">crisis </span>
   <span class="font10">criteria: </span>
   <span class="font10">cross-over </span>
   <span class="font10">curve </span>
   <span class="font10">d'Hebron </span>
   <span class="font10">date, </span>
   <span class="font10">day, </span>
   <span class="font10">days/month, </span>
   <span class="font10">days: </span>
   <span class="font10">debate. </span>
   <span class="font10">delayed </span>
   <span class="font10">delivery </span>
   <span class="font10">demographics, </span>
   <span class="font10">depend </span>
   <span class="font10">depending </span>
   <span class="font10">deposits </span>
   <span class="font10">derived </span>
   <span class="font10">determining </span>
   <span class="font10">deviation </span>
   <span class="font10">diary. </span>
   <span class="font10">diastolic </span>
   <span class="font10">differed </span>
   <span class="font10">disabilities. </span>
   <span class="font10">disutility </span>
   <span class="font10">doctor </span>
   <span class="font10">downloads </span>
   <span class="font10">dura. </span>
   <span class="font10">duration) </span>
   <span class="font10">effective, </span>
   <span class="font10">elicited </span>
   <span class="font10">elucidate </span>
   <span class="font10">em; </span>
   <span class="font10">emerged </span>
   <span class="font10">emerging </span>
   <span class="font10">encouraging </span>
   <span class="font10">energy </span>
   <span class="font10">enhance </span>
   <span class="font10">enhanced </span>
   <span class="font10">enrolled, </span>
   <span class="font10">ensure </span>
   <span class="font10">erenumab, </span>
   <span class="font10">erenumab. </span>
   <span class="font10">estradiol </span>
   <span class="font10">estrogens </span>
   <span class="font10">evaluation. </span>
   <span class="font10">events, </span>
   <span class="font10">exacerbations </span>
   <span class="font10">exact </span>
   <span class="font10">examination, </span>
   <span class="font10">exceeded </span>
   <span class="font10">excellent </span>
   <span class="font10">exist </span>
   <span class="font10">experiencing </span>
   <span class="font10">experiments </span>
   <span class="font10">expertise </span>
   <span class="font10">extended </span>
   <span class="font10">extensive </span>
   <span class="font10">extracranial </span>
   <span class="font10">face </span>
   <span class="font10">fact, </span>
   <span class="font10">failures. </span>
   <span class="font10">fasting </span>
   <span class="font10">favor </span>
   <span class="font10">favorable </span>
   <span class="font10">felt </span>
   <span class="font10">fifth </span>
   <span class="font10">first, </span>
   <span class="font10">fit </span>
   <span class="font10">fixed </span>
   <span class="font10">focused </span>
   <span class="font10">forehead </span>
   <span class="font10">formation </span>
   <span class="font10">forward </span>
   <span class="font10">found. </span>
   <span class="font10">fourth </span>
   <span class="font10">framework </span>
   <span class="font10">fremanezumab-treated </span>
   <span class="font10">from: </span>
   <span class="font10">functions </span>
   <span class="font10">gammaCore®) </span>
   <span class="font10">gastrointestinal </span>
   <span class="font10">gave </span>
   <span class="font10">genetically </span>
   <span class="font10">glutamate </span>
   <span class="font10">grants, </span>
   <span class="font10">group). </span>
   <span class="font10">guidance </span>
   <span class="font10">guided </span>
   <span class="font10">hazard </span>
   <span class="font10">headache-specific </span>
   <span class="font10">hemorrhage </span>
   <span class="font10">highlight </span>
   <span class="font10">homozygous </span>
   <span class="font10">hospitalization </span>
   <span class="font10">hospitalization, </span>
   <span class="font10">hydroxy </span>
   <span class="font10">hyperexcitability </span>
   <span class="font10">hypertension, </span>
   <span class="font10">hypoperfusion </span>
   <span class="font10">hypothesized </span>
   <span class="font10">illness </span>
   <span class="font10">images. </span>
   <span class="font10">impact, </span>
   <span class="font10">implant </span>
   <span class="font10">implanted </span>
   <span class="font10">inappropriate </span>
   <span class="font10">income, </span>
   <span class="font10">incremental </span>
   <span class="font10">independently </span>
   <span class="font10">ineffective </span>
   <span class="font10">infrequent </span>
   <span class="font10">injections, </span>
   <span class="font10">insights </span>
   <span class="font10">instruments </span>
   <span class="font10">insulin </span>
   <span class="font10">integrity </span>
   <span class="font10">interest, </span>
   <span class="font10">interest. </span>
   <span class="font10">intractable </span>
   <span class="font10">investigations </span>
   <span class="font10">invited </span>
   <span class="font10">involve </span>
   <span class="font10">kHz </span>
   <span class="font10">label </span>
   <span class="font10">lacking. </span>
   <span class="font10">lacks </span>
   <span class="font10">laser </span>
   <span class="font10">lasted </span>
   <span class="font10">late-.% </span>
   <span class="font10">leave </span>
   <span class="font10">levels, </span>
   <span class="font10">life-style, </span>
   <span class="font10">linked </span>
   <span class="font10">load </span>
   <span class="font10">long-lasting </span>
   <span class="font10">low-frequency </span>
   <span class="font10">makes </span>
   <span class="font10">male-to-female </span>
   <span class="font10">managed </span>
   <span class="font10">management, </span>
   <span class="font10">managing </span>
   <span class="font10">manifestations </span>
   <span class="font10">maps </span>
   <span class="font10">maybe </span>
   <span class="font10">measured. </span>
   <span class="font10">mechanisms. </span>
   <span class="font10">medial </span>
   <span class="font10">medically </span>
   <span class="font10">men, </span>
   <span class="font10">mental </span>
   <span class="font10">methods, </span>
   <span class="font10">methods: </span>
   <span class="font10">metrics </span>
   <span class="font10">microstructural </span>
   <span class="font10">migraine" </span>
   <span class="font10">migraine). </span>
   <span class="font10">migraineurs, </span>
   <span class="font10">mimic </span>
   <span class="font10">minimal </span>
   <span class="font10">minimal/no, </span>
   <span class="font10">minutes, </span>
   <span class="font10">minutes. </span>
   <span class="font10">mm) </span>
   <span class="font10">models. </span>
   <span class="font10">modest, </span>
   <span class="font10">modulate </span>
   <span class="font10">molecule </span>
   <span class="font10">monitored </span>
   <span class="font10">monthly. </span>
   <span class="font10">morning </span>
   <span class="font10">multimodal </span>
   <span class="font10">n=) </span>
   <span class="font10">n=, </span>
   <span class="font10">nVNS. </span>
   <span class="font10">needed. </span>
   <span class="font10">newly </span>
   <span class="font10">nociceptors, </span>
   <span class="font10">novo </span>
   <span class="font10">nuclei, </span>
   <span class="font10">numerically </span>
   <span class="font10">nutraceutical </span>
   <span class="font10">observed. </span>
   <span class="font10">obtain </span>
   <span class="font10">offer </span>
   <span class="font10">one-year </span>
   <span class="font10">optical </span>
   <span class="font10">original </span>
   <span class="font10">outcome), </span>
   <span class="font10">outcomes. </span>
   <span class="font10">ovale </span>
   <span class="font10">p&amp;lt;.. </span>
   <span class="font10">p=. </span>
   <span class="font10">p=.; </span>
   <span class="font10">pain; </span>
   <span class="font10">papers </span>
   <span class="font10">participating </span>
   <span class="font10">parts </span>
   <span class="font10">patch </span>
   <span class="font10">pathophysiology. </span>
   <span class="font10">pathway. </span>
   <span class="font10">patterns, </span>
   <span class="font10">peculiar </span>
   <span class="font10">perceive </span>
   <span class="font10">perform </span>
   <span class="font10">period) </span>
   <span class="font10">perspective </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">pharmacology </span>
   <span class="font10">phases. </span>
   <span class="font10">phenomenon </span>
   <span class="font10">physiotherapy </span>
   <span class="font10">pill </span>
   <span class="font10">place </span>
   <span class="font10">placebo-treated </span>
   <span class="font10">placebo; </span>
   <span class="font10">points, </span>
   <span class="font10">poorer </span>
   <span class="font10">poorly </span>
   <span class="font10">positivity </span>
   <span class="font10">possibility </span>
   <span class="font10">pre-specified </span>
   <span class="font10">preceded </span>
   <span class="font10">predisposing </span>
   <span class="font10">prescholar </span>
   <span class="font10">prescribing </span>
   <span class="font10">prevent </span>
   <span class="font10">preventives </span>
   <span class="font10">probable </span>
   <span class="font10">procedure. </span>
   <span class="font10">process. </span>
   <span class="font10">progestogens </span>
   <span class="font10">prominent </span>
   <span class="font10">prone </span>
   <span class="font10">proportional </span>
   <span class="font10">prostaglandin </span>
   <span class="font10">protein, </span>
   <span class="font10">protocol, </span>
   <span class="font10">protocols </span>
   <span class="font10">proven </span>
   <span class="font10">provokes </span>
   <span class="font10">psychotic </span>
   <span class="font10">pt;} </span>
   <span class="font10">pterygopalatine </span>
   <span class="font10">ptosis </span>
   <span class="font10">pts </span>
   <span class="font10">public </span>
   <span class="font10">pulsating </span>
   <span class="font10">purpose </span>
   <span class="font10">raised </span>
   <span class="font10">range: </span>
   <span class="font10">ranking </span>
   <span class="font10">rapidly </span>
   <span class="font10">rare, </span>
   <span class="font10">rate. </span>
   <span class="font10">ratings </span>
   <span class="font10">rats </span>
   <span class="font10">reason, </span>
   <span class="font10">receptor. </span>
   <span class="font10">reflecting </span>
   <span class="font10">regard </span>
   <span class="font10">regional </span>
   <span class="font10">registry </span>
   <span class="font10">relapse </span>
   <span class="font10">relating </span>
   <span class="font10">reported, </span>
   <span class="font10">reporting </span>
   <span class="font10">represented </span>
   <span class="font10">respectively; </span>
   <span class="font10">responders. </span>
   <span class="font10">resting </span>
   <span class="font10">returned </span>
   <span class="font10">reversion </span>
   <span class="font10">review. </span>
   <span class="font10">rhythm </span>
   <span class="font10">risk, </span>
   <span class="font10">rule </span>
   <span class="font10">sample. </span>
   <span class="font10">sampling </span>
   <span class="font10">scale. </span>
   <span class="font10">scheduled </span>
   <span class="font10">scored </span>
   <span class="font10">searched </span>
   <span class="font10">sec </span>
   <span class="font10">sectors </span>
   <span class="font10">sensitivity, </span>
   <span class="font10">sensitization. </span>
   <span class="font10">shared </span>
   <span class="font10">shorter </span>
   <span class="font10">signaling </span>
   <span class="font10">signals </span>
   <span class="font10">signed </span>
   <span class="font10">sizes </span>
   <span class="font10">sleep. </span>
   <span class="font10">smaller </span>
   <span class="font10">society. </span>
   <span class="font10">socioeconomic </span>
   <span class="font10">solution </span>
   <span class="font10">somatosensory </span>
   <span class="font10">specialists </span>
   <span class="font10">specialists, </span>
   <span class="font10">spread </span>
   <span class="font10">stages </span>
   <span class="font10">statements </span>
   <span class="font10">status. </span>
   <span class="font10">stimulator </span>
   <span class="font10">subcortical </span>
   <span class="font10">subgroup, </span>
   <span class="font10">subsidiaries. </span>
   <span class="font10">subtype </span>
   <span class="font10">sudden </span>
   <span class="font10">supporting </span>
   <span class="font10">suppression </span>
   <span class="font10">surgery </span>
   <span class="font10">suspect </span>
   <span class="font10">symptom, </span>
   <span class="font10">syndromes </span>
   <span class="font10">systematically </span>
   <span class="font10">systemic </span>
   <span class="font10">systolic </span>
   <span class="font10">team </span>
   <span class="font10">territory </span>
   <span class="font10">that, </span>
   <span class="font10">theory </span>
   <span class="font10">thrombophilia </span>
   <span class="font10">tolerated </span>
   <span class="font10">tools </span>
   <span class="font10">topic </span>
   <span class="font10">topiramate, </span>
   <span class="font10">traditional </span>
   <span class="font10">trained </span>
   <span class="font10">traits </span>
   <span class="font10">treatment: </span>
   <span class="font10">trends </span>
   <span class="font10">trigger. </span>
   <span class="font10">try </span>
   <span class="font10">twice </span>
   <span class="font10">ultramicronized </span>
   <span class="font10">unaffected </span>
   <span class="font10">uncertain </span>
   <span class="font10">underlie </span>
   <span class="font10">unemployment </span>
   <span class="font10">updated </span>
   <span class="font10">used. </span>
   <span class="font10">valuable </span>
   <span class="font10">variant </span>
   <span class="font10">variants </span>
   <span class="font10">vary </span>
   <span class="font10">vasoactive </span>
   <span class="font10">version) </span>
   <span class="font10">visited </span>
   <span class="font10">visits. </span>
   <span class="font10">wave </span>
   <span class="font10">weeks, </span>
   <span class="font10">weight. </span>
   <span class="font10">well-known </span>
   <span class="font10">which, </span>
   <span class="font10">winter </span>
   <span class="font10">words: </span>
   <span class="font10">work. </span>
   <span class="font10">workdays </span>
   <span class="font10">yet. </span>
   <span class="font10">yrs; </span>
   <span class="font10">zolmitriptan </span>
   <span class="font10">±SD </span>
   <span class="font10">χ() </span>
  </p>
 </body>
</html>
